Cluster headache, strict, including avohilmo

G6_CLUSTHEADACHE_STRICT_INCLAVO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G44.0 1 out of 7 registries used, show all original rules.	1244
4. Check minimum number of events None	1244
5. Include endpoints G6_CLUSTHEADACHE_STRICT	2275
6. Filter based on genotype QC (FinnGen only)	2049

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF6

NAME	G6_CLUSTHEADACHE_STRICT_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_CLUSTHEADACHE_STRICT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G440
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cluster headache, strict, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Cluster headache, strict

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11512	5294	6127
Only index persons	11219	5224	5995
Unadjusted period prevalence (%)
Whole population	0.16	0.15	0.17
Only index persons	0.21	0.19	0.23
Median age at first event (years)
Whole population	41.46	42.16	40.92
Only index persons	41.26	42.00	40.63

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2049	1262	787
Unadjusted period prevalence (%)	0.41	0.45	0.36
Median age at first event (years)	45.90	44.18	48.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2147: Matched controls
21470

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G44.0

ICD-10 Finland

Cluster headache syndrome

+∞

307.7

2147

N02CC03

ATC

zolmitriptan; nasal, oral

12.1

307.7

635

723

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

8.4

307.7

606

963

G43.3

ICD-10 Finland

Complicated migraine

16.9

307.7

305

208

R51.80

ICD-10 Finland

Headache

7.7

307.7

1072

2454

C08DA01

ATC

verapamil; systemic

62.6

307.7

909

249

G43.9

ICD-10 Finland

Migraine, unspecified

8.3

307.7

612

985

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

22.7

307.7

1579

2338

N03AX11

ATC

topiramate; oral

24.8

307.7

512

268

N02CC07

ATC

frovatriptan; oral

8.9

305.2

427

585

N02CC04

ATC

rizatriptan; oral

7.6

296.8

487

799

3007

Kela drug reimbursment

Erenumab and fremanezumab

17.8

292.1

245

154

G44.2

ICD-10 Finland

Tension-type headache

4.9

246.3

722

2003

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

5.9

241.4

520

1106

G44.8

ICD-10 Finland

Other specified headache syndromes

14.6

231.7

215

162

N03AG01

ATC

valproic acid; systemic, rectal

6.7

221.3

396

701

N02CC06

ATC

eletriptan; oral

7.9

219.9

331

487

N02CD01

ATC

erenumab; parenteral

22.0

217.0

163

N03AX12

ATC

[U] gabapentin; oral

4.6

216.0

673

1937

H02AB06

ATC

prednisolone; systemic

4.0

202.0

1438

7254

N02CD03

ATC

fremanezumab; systemic

16.2

192.3

167

111

N89

ICPC

Migraine

6.7

185.8

326

562

G43.8

ICD-10 Finland

Other migraine

11.7

183.4

195

182

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.2

181.2

433

994

N01

ICPC

Headache

4.2

177.8

602

1817

G43

ICD-10 Finland

Migraine

5.2

169.2

395

886

N02CC05

ATC

almotriptan; oral

6.4

159.1

285

499

N06AA09

ATC

amitriptyline; systemic

5.1

157.8

377

860

N03AX16

ATC

[U] pregabalin

3.4

146.9

741

2876

N02CC02

ATC

naratriptan; oral

10.2

146.9

171

181

N02CD02

ATC

galcanezumab; parenteral

27.0

142.3

C09CA06

ATC

candesartan; oral

3.2

138.7

792

3294

N02AX02

ATC

tramadol; systemic, rectal

3.0

134.5

1179

6208

R51

ICD-10 Finland

Headache

4.9

133.2

330

771

M03AX01

ATC

botulinum toxin; parenteral

10.5

131.0

148

150

C07AA05

ATC

propranolol; systemic

3.2

129.8

754

3147

R51.81

ICD-10 Finland

Facial pain NOS

8.4

127.3

172

220

H02AB07

ATC

prednisone; oral

3.7

120.6

451

1426

A03FA01

ATC

metoclopramide; systemic, rectal

3.0

114.8

692

2919

N02CD06

ATC

rimegepant; oral

15.5

111.5

G43.2

ICD-10 Finland

Status migrainosus

24.8

111.5

N90

ICPC

Cluster headache

368.3

106.2

106

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.1

105.0

331

924

AA1AD

NOMESCO Finland

CT of head and brain

2.8

103.6

706

3156

N02CX04, ,

ATC

9.7

102.7

122

132

N03AF01

ATC

carbamazepine; oral, rectal

5.5

102.5

213

425

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

101.2

1083

6043

G50.0

ICD-10 Finland

Trigeminal neuralgia

9.5

98.0

118

130

N06AX21

ATC

duloxetine; oral

3.3

97.5

454

1633

M01AE02

ATC

naproxen; oral, rectal

2.7

96.8

1525

10152

G50.1

ICD-10 Finland

Atypical facial pain

9.3

96.6

119

135

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

93.6

345

1069

M03BX02

ATC

tizanidine; oral

2.8

91.1

1638

11467

N06AX16

ATC

venlafaxine; oral

2.9

90.6

541

2233

N03AX09

ATC

lamotrigine; oral

4.2

89.7

266

707

N02BF01

ATC

gabapentin; oral

3.4

87.5

370

1249

M03BC01

ATC

orphenadrine (citrate); systemic

2.6

84.0

718

3533

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

11.6

81.6

A02BC02

ATC

pantoprazole; systemic

2.6

80.3

1602

11406

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

79.8

1137

6979

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

79.2

885

4890

M01AG02

ATC

tolfenamic acid; oral, rectal

2.7

77.0

500

2138

G44

ICD-10 Finland

Other headache syndromes

18.4

76.1

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

75.9

344

1205

A02BC05

ATC

esomeprazole; systemic

2.3

74.6

1010

6014

N06AX11

ATC

mirtazapine; oral

2.3

74.6

914

5222

M03BX01

ATC

baclofen; systemic

6.8

74.5

120

186

N06AA10

ATC

nortriptyline; systemic

6.7

72.8

118

184

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

72.7

756

4018

C07AB07

ATC

bisoprolol; oral

2.3

71.7

964

5699

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.3

70.4

301

1016

M79.6

ICD-10 Finland

Pain in limb

2.2

69.5

1135

7228

M54.5

ICD-10 Finland

Low back pain

2.2

67.9

1017

6239

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

66.7

682

3574

M03BC51

ATC

orphenadrine, combinations; systemic

2.3

66.6

750

4094

C07AB02

ATC

metoprolol; systemic

2.8

64.0

391

1607

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

60.8

459

2089

M54.4

ICD-10 Finland

Lumbago with sciatica

2.4

60.8

551

2725

H57.1

ICD-10 Finland

Ocular pain

4.0

60.1

184

497

R06.0

ICD-10 Finland

Dyspnoea

2.3

60.0

640

3389

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

59.9

1114

7310

M79.7

ICD-10 Finland

Fibromyalgia

4.3

59.4

160

393

N05AH04

ATC

quetiapine; oral

2.3

58.4

550

2759

A01

ICPC

Pain general/multiple sites

2.9

58.2

308

1170

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

57.9

661

3591

R42

ICD-10 Finland

Dizziness and giddiness

2.3

57.8

539

2692

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.5

57.7

209

633

N03AE01

ATC

clonazepam; systemic

3.7

56.3

192

558

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.5

55.8

425

1936

N05BA01

ATC

diazepam; systemic, rectal

2.7

54.5

350

1467

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.1

54.4

163

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

53.7

511

2564

N05BA04

ATC

oxazepam; oral

2.1

53.2

663

3707

M01AB05

ATC

diclofenac; systemic, rectal

2.1

53.1

1545

11720

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

52.5

758

4475

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

52.3

320

1308

N02CA01

ATC

dihydroergotamine; nasal, systemic

22.7

51.9

N05AN01

ATC

lithium; oral

4.7

51.8

125

281

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

51.3

391

1776

A02BC03

ATC

lansoprazole; oral

2.1

51.1

632

3514

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

18.2

50.8

R03AC02

ATC

salbutamol; inhalant

2.0

50.1

1336

9720

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

49.0

315

1317

N02BE01

ATC

paracetamol; systemic, rectal

3.2

48.8

1980

16919

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

48.7

972

6389

R53

ICD-10 Finland

Malaise and fatigue

2.1

47.9

656

3774

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.4

47.8

377

1735

N02CD07, ,

ATC

15.3

47.7

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

47.7

517

2720

L01

ICPC

Neck symptom/complaint

2.2

47.2

482

2476

L03

ICPC

Low back symptom/complaint

2.0

46.9

766

4687

R52.2

ICD-10 Finland

Other chronic pain

3.9

46.5

144

391

N05CF01

ATC

zopiclone; oral

2.0

46.4

690

4081

N02BF02

ATC

pregabalin; oral

3.0

45.7

221

794

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.3

45.6

120

289

A02BC01

ATC

omeprazole; systemic

2.1

45.3

596

3369

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

45.1

192

641

M01AH05

ATC

etoricoxib; oral

2.0

44.7

1479

11362

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

44.6

245

943

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

43.8

481

2534

K07.60

ICD-10 Finland

Snapping jaw

3.0

43.6

202

708

3AX01, ,

NOMESCO Finland

16.4

43.6

H02AB04

ATC

methylprednisolone; systemic

2.4

43.6

357

1666

R52.9

ICD-10 Finland

Pain, unspecified

2.5

43.3

298

1284

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.1

42.9

122

311

M01AB01

ATC

indometacin; systemic, rectal

3.4

42.8

162

503

M25.5

ICD-10 Finland

Pain in joint

1.9

42.1

862

5636

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

41.4

719

4451

N06AB04

ATC

citalopram; systemic

2.1

41.1

506

2777

N02AA05

ATC

oxycodone; systemic

2.3

40.3

344

1630

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

40.2

426

2206

M79.1

ICD-10 Finland

Myalgia

2.1

40.2

440

2308

M35.7

ICD-10 Finland

Hypermobility syndrome

5.4

39.7

154

N06AB10

ATC

escitalopram; oral

2.0

39.6

593

3482

J01AA02

ATC

doxycycline; systemic

2.0

39.5

1679

13710

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

39.4

237

954

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.3

39.3

159

514

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

39.3

321

1492

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

38.8

238

967

F45.8

ICD-10 Finland

Other somatoform disorders

2.6

38.8

255

1072

P01AB01

ATC

metronidazole; oral, rectal

1.8

38.7

936

6399

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

8.9

38.5

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

37.6

294

1338

A02BA02

ATC

ranitidine; systemic

2.2

37.2

384

1962

M54.2

ICD-10 Finland

Cervicalgia

2.5

37.1

252

1075

R03DC03

ATC

montelukast; oral

2.1

36.8

448

2437

N03AX15

ATC

zonisamide; oral

13.8

36.5

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

36.5

316

1503

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

36.3

482

2704

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.6

35.8

124

R02

ICPC

Shortness of breath/dyspnoea

2.3

35.7

312

1488

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

35.7

228

944

TAB00

NOMESCO Finland

Lumbar puncture

3.2

35.6

149

491

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

35.6

571

3414

D01

ICPC

Abdominal pain/cramps general

2.2

35.5

353

1776

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.5

35.5

198

UJF32

NOMESCO Finland

Coloscopy

2.0

35.2

514

2976

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

35.1

1372

10679

J01FF01

ATC

clindamycin; systemic

1.9

34.8

616

3797

R03BB04

ATC

tiotropium bromide; inhalant

2.7

34.6

202

800

H53.1

ICD-10 Finland

Subjective visual disturbances

2.7

34.4

200

790

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.4

34.3

127

388

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

34.0

534

3164

A11

ICPC

Chest pain NOS

2.6

34.0

205

825

R07.3

ICD-10 Finland

Other chest pain

2.4

33.6

267

1222

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.3

33.4

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

33.1

1293

9980

PA6AD

NOMESCO Finland

CT of neck arteries

3.6

33.0

114

333

H01

ICPC

Ear pain/earache

2.1

32.5

334

1697

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

32.3

1114

8288

Z3231

NOMESCO Finland

Registered nurse

1.9

31.9

569

3500

D06

ICPC

Abdominal pain localized other

2.4

31.5

246

1116

R05

ICPC

Cough

1.8

31.5

593

3709

ZX114

NOMESCO Finland

Intramuscular

5.4

31.4

117

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

31.3

492

2906

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

31.1

1226

9417

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.8

30.8

161

601

R21

ICPC

Throat symptom/complaint

1.8

30.7

603

3813

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

30.5

339

1773

J01MA02

ATC

ciprofloxacin; systemic

1.7

30.4

764

5185

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

30.2

520

3156

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

30.1

199

836

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.8

30.0

153

564

J01FA10

ATC

azithromycin; systemic

1.7

29.8

1360

10803

R4110

NOMESCO Finland

Physiotherapy

1.8

29.7

580

3658

N06AX12

ATC

bupropion; oral

2.3

29.7

259

1231

R55

ICD-10 Finland

Syncope and collapse

2.4

29.5

219

970

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

29.4

118

379

M01AH01

ATC

celecoxib; oral

2.0

29.3

361

1958

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

29.2

256

1218

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

29.2

956

6949

L17

ICPC

Foot/toe symptom/complaint

1.7

28.7

666

4405

A04

ICPC

Weakness/tiredness general

2.0

28.5

375

2081

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

28.3

132

463

N06AX26

ATC

vortioxetine; oral

2.2

28.3

249

1187

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.2

28.2

115

373

N03AF02

ATC

oxcarbazepine; oral

3.4

28.0

104

318

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

27.5

488

2980

Z71.8

ICD-10 Finland

Other specified counselling

1.7

27.5

817

5766

J01DB01

ATC

cefalexin; oral

2.0

27.3

1820

15884

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

27.2

221

1018

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

27.0

1674

14250

N05AB04

ATC

prochlorperazine; systemic, rectal

5.2

27.0

107

G81.9

ICD-10 Finland

Hemiplegia, unspecified

6.5

26.9

M54.3

ICD-10 Finland

Sciatica

2.7

26.9

156

614

K30

ICD-10 Finland

Functional dyspepsia

2.1

26.9

291

1503

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

26.9

153

597

Z3226

NOMESCO Finland

Physiotherapist

1.9

26.8

378

2142

Z2445

NOMESCO Finland

Psychologist

2.9

26.8

132

477

XCK00

NOMESCO Finland

Perimetry

3.1

26.7

118

401

J01FA06

ATC

roxithromycin; oral

1.7

26.6

839

5996

A03

ICPC

Fever

1.8

26.6

482

2957

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

26.6

336

1834

N05CF02

ATC

zolpidem; oral

1.9

26.2

407

2379

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

26.2

312

1667

R01AD09

ATC

mometasone; nasal

1.6

26.1

1077

8220

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

26.0

225

1063

G47.3

ICD-10 Finland

Sleep apnoea

1.8

25.7

530

3373

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.6

25.7

241

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

25.7

1627

13804

SPAT1060

SPAT

Administration of oxygen

24.4

25.7

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.2

25.6

223

1056

D11

ICPC

Diarrhoea

2.0

25.6

333

1835

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

25.5

698

4797

J02AC01

ATC

fluconazole; systemic

1.6

25.3

891

6525

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

25.1

722

5024

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.6

25.1

134

G54.0

ICD-10 Finland

Brachial plexus disorders

3.2

24.7

102

333

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.0

24.6

183

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

24.6

400

2369

G44.4

ICD-10 Finland

Drug-induced headache, not elsewhere classified

27.9

24.5

N07BA03

ATC

varenicline; oral

2.6

24.5

149

601

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.2

24.4

305

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

24.3

129

485

R74

ICPC

Upper respiratory infection acute

1.6

24.3

889

6553

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.5

24.3

241

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

24.2

274

1435

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

24.2

315

1733

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.4

24.0

267

Z00.0

ICD-10 Finland

General medical examination

1.8

24.0

423

2565

S06.0

ICD-10 Finland

Concussion

2.1

24.0

264

1369

R96

ICPC

Asthma

2.2

23.9

223

1085

R11

ICD-10 Finland

Nausea and vomiting

2.2

23.8

214

1026

WX290

NOMESCO Finland

Other blockage of nerve

1.6

23.7

1202

9547

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

23.6

309

1703

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

23.6

679

4709

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

23.5

817

5934

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

23.5

159

674

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

23.4

112

398

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

23.4

281

1503

P01

ICPC

Feeling anxious/nervous/tense

1.8

23.3

399

2396

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

23.3

539

3530

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

23.2

412

2502

M54.1

ICD-10 Finland

Radiculopathy

2.9

23.2

113

406

P76

ICPC

Depressive disorder

2.2

23.1

215

1046

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.6

22.9

221

K08.80

ICD-10 Finland

Toothache NOS

2.0

22.8

262

1379

M89.0

ICD-10 Finland

Algoneurodystrophy

5.6

22.8

S18

ICPC

Laceration/cut

1.6

22.5

926

6977

SPAT1050

SPAT

Extensive neurological examination

4.2

22.4

142

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

22.4

279

1510

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

22.4

118

442

KH1AD

NOMESCO Finland

CT of urinary organs

3.1

22.3

322

R01AD08

ATC

fluticasone; nasal

1.6

22.2

671

4695

N06AB03

ATC

fluoxetine; oral

1.9

22.1

288

1584

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

4.4

22.1

127

R06AE07

ATC

cetirizine; oral

1.6

21.9

998

7679

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

21.9

436

2733

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

21.8

290

1605

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

21.8

163

723

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.5

21.8

144

604

SPAT1254

SPAT

Administration of medicine

2.0

21.7

280

1533

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

21.7

781

5694

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

21.6

280

1535

R03BA05

ATC

fluticasone; inhalant

1.8

21.6

406

2502

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

21.6

159

700

N06AB06

ATC

sertraline; oral

1.9

21.6

306

1729

R03BA01

ATC

beclometasone; inhalant

1.9

21.6

292

1625

R01AD58

ATC

fluticasone, combinations; nasal

1.6

21.6

655

4584

H92.0

ICD-10 Finland

Otalgia

2.3

21.5

180

837

N06AX22

ATC

agomelatine; oral

3.1

21.5

297

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

21.4

507

3331

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

26.7

21.3

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

21.3

627

4351

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.6

21.1

111

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

21.0

615

4261

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

20.9

307

1754

N06AA12

ATC

doxepin; systemic

2.8

20.9

110

412

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

20.9

107

395

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.3

20.9

245

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.8

20.9

108

401

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

20.9

154

679

R25.2

ICD-10 Finland

Cramp and spasm

3.6

20.9

196

R50.9

ICD-10 Finland

Fever, unspecified

1.8

20.8

341

2015

A06AD11

ATC

lactulose; oral

2.0

20.8

233

1214

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

20.7

132

544

L12

ICPC

Hand/finger symptom/complaint

1.7

20.7

404

2515

N05BA12

ATC

alprazolam; oral

2.1

20.7

222

1139

XF402

NOMESCO Finland

ECG with work load test

2.2

20.6

181

859

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

20.5

286

1606

SAA04

NOMESCO Finland

Special examination of mouth

2.4

20.5

139

590

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

20.4

244

1300

N17

ICPC

Vertigo/dizziness

2.0

20.4

251

1352

R4120

NOMESCO Finland

Occupational therapy

2.3

20.3

155

693

Z01.2

ICD-10 Finland

Dental examination

1.5

20.2

1068

8436

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

20.0

229

1201

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.3

20.0

231

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

19.9

124

506

X58

ICD-10 Finland

Exposure to other specified factors

1.8

19.8

370

2273

N30.0

ICD-10 Finland

Acute cystitis

1.8

19.7

358

2179

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

19.7

239

1280

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

19.6

322

1904

P06

ICPC

Sleep disturbance

1.8

19.5

332

1982

J01.1

ICD-10 Finland

Acute frontal sinusitis

3.6

19.4

177

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

19.4

711

5175

G90.2

ICD-10 Finland

Horner syndrome

15.7

19.3

WX002

NOMESCO Finland

Sedation and analgesia

1.8

19.2

348

2116

R1250

NOMESCO Finland

Evaluation of functional capability

3.4

19.2

207

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

19.2

202

1028

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

19.2

328

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

19.1

268

1507

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

19.1

236

1272

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.4

19.1

213

J01DA01

ATC

[U] cefalexin

1.5

18.9

1283

10623

XKD00

NOMESCO Finland

Uroflowmetry

2.0

18.7

221

1172

U07

ICPC

Urine symptom/complaint other

2.2

18.7

169

811

L02

ICPC

Back symptom/complaint

1.9

18.7

273

1555

ZXA05

NOMESCO Finland

Left side

1.7

18.6

405

2591

D02

ICPC

Abdominal pain epigastric

2.2

18.5

159

747

M01AE01

ATC

ibuprofen; systemic, rectal

2.2

18.5

2000

18527

N04BC05

ATC

pramipexole; oral

2.3

18.4

147

671

N02CD05

ATC

eptinezumab; parenteral

30.3

18.3

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

18.3

279

1610

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

6.9

18.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

18.3

164

785

H53.2

ICD-10 Finland

Diplopia

2.9

18.2

293

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

18.1

145

662

J01FA09

ATC

clarithromycin; systemic

1.5

18.1

679

4950

R05

ICD-10 Finland

Cough

1.6

18.1

458

3045

K02.1

ICD-10 Finland

Caries of dentine

1.5

18.1

1364

11492

WX402

NOMESCO Finland

General anaesthesia

1.6

18.1

491

3322

SBB10

NOMESCO Finland

Dental impressions

2.1

18.0

176

870

AA1AA

NOMESCO Finland

Head X-ray examination

6.3

18.0

R10.0

ICD-10 Finland

Acute abdomen

2.8

18.0

334

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

18.0

123

524

L08

ICPC

Shoulder symptom/complaint

1.6

18.0

476

3199

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

17.9

898

6956

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.5

17.9

182

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

17.8

308

SPAT1255

SPAT

Intravenous administration of medicine

2.4

17.8

131

577

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

17.8

506

3460

Z2446

NOMESCO Finland

Social worker

2.2

17.7

155

734

R01AD12

ATC

fluticasone furoate; nasal

1.5

17.6

767

5766

3468X

ICD-9 Finland

Migraine, Other forms of migraine

95.9

17.6

N06AX03

ATC

mianserin; oral

2.6

17.6

103

408

C01CA24

ATC

epinephrine; parenteral

2.1

17.5

182

921

SPAT1283

SPAT

Restricted health certificate

1.6

17.5

484

3286

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.7

17.4

380

N80.0

ICD-10 Finland

Endometriosis of uterus

3.3

17.4

210

ZXA10

NOMESCO Finland

Bilateral

1.8

17.4

313

1897

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.8

17.4

329

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.0

17.3

125

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

17.1

423

2791

P03

ICPC

Feeling depressed

1.8

17.1

288

1711

L28

ICPC

Limited function/disability (L)

1.8

17.1

294

1758

M48.0

ICD-10 Finland

Spinal stenosis

2.0

17.1

188

972

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.6

17.0

154

R03AC03

ATC

terbutaline; inhalant

1.8

17.0

298

1791

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

17.0

127

563

ZXE00

NOMESCO Finland

One hour or less

1.5

17.0

767

5800

SPAT1104

SPAT

Monitoring of emergency patient

2.3

16.9

128

570

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

16.8

551

3885

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

16.8

190

991

SFA10

NOMESCO Finland

One-surface restoration

1.5

16.8

1235

10273

M77.1

ICD-10 Finland

Lateral epicondylitis

1.9

16.8

225

1244

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

16.8

140

650

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.4

16.7

185

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

16.7

126

561

M01AH02

ATC

rofecoxib; oral

1.9

16.7

208

1123

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

16.6

144

679

U01

ICPC

Dysuria/painful urination

2.0

16.5

177

906

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

16.5

142

668

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

16.5

182

J45

ICD-10 Finland

Asthma

1.8

16.5

244

1394

M02AA07

ATC

piroxicam; topical

1.5

16.4

616

4471

C07AB12

ATC

nebivolol; oral

3.0

16.4

255

R06AX22

ATC

ebastine; oral

1.6

16.4

400

2627

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

16.4

220

1218

K04.0

ICD-10 Finland

Pulpitis

1.8

16.3

253

1465

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

16.3

219

1212

S01EC01

ATC

acetazolamide; systemic

3.9

16.2

122

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

6.6

16.2

R13

ICD-10 Finland

Dysphagia

2.2

16.2

148

713

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

16.2

141

667

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

16.1

182

950

J01EA01

ATC

trimethoprim; systemic

1.6

16.0

467

3203

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

16.0

148

717

SPAT1263

SPAT

Sampling

1.5

15.9

832

6456

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

15.9

221

1237

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

15.9

202

1098

M01AC06

ATC

meloxicam; systemic, rectal

1.5

15.8

668

4964

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.4

15.8

107

454

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

15.7

186

986

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

15.7

114

499

R52.1

ICD-10 Finland

Chronic intractable pain

4.7

15.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

15.5

305

1891

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.1

15.5

215

B02AA02

ATC

tranexamic acid; systemic

1.7

15.5

327

2067

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

15.5

129

599

M01AB55

ATC

diclofenac, combinations; oral

2.4

15.4

111

484

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.5

15.4

150

UKC02

NOMESCO Finland

Cystoscopy

1.8

15.4

237

1369

R4110, ,

SPAT

1.8

15.4

253

1491

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

15.4

170

880

P29

ICPC

Psychological sympt/compl other

1.9

15.3

222

1258

ZY010

NOMESCO Finland

Hospital outpatient

2.1

15.3

145

709

S29

ICPC

Skin symptom/complaint other

1.6

15.2

406

2721

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

5.3

15.1

N95

ICPC

Tension headache

6.1

15.1

N05CD07

ATC

temazepam; oral

2.0

15.1

167

864

L86

ICPC

Back syndrome with radiating pain

2.1

15.0

139

673

A02BA04

ATC

nizatidine; systemic

2.2

14.9

122

562

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

14.9

289

1784

G04CA02

ATC

tamsulosin; oral

1.7

14.9

303

1895

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.8

14.9

235

1368

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.1

14.8

210

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

14.8

121

557

SPAT1301

SPAT

No procedures

1.5

14.8

555

4016

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

14.7

100

425

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

14.7

109

482

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

14.7

295

1839

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

14.6

130

620

M01AX17

ATC

nimesulide; oral

1.6

14.6

386

2580

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

14.5

299

1875

79199

ICD-8 Finland

Headache

5.0

14.5

XF404

NOMESCO Finland

Ambulatory ECG

2.1

14.5

145

723

Z2221

NOMESCO Finland

Medical doctor

1.5

14.5

545

3943

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

14.4

120

557

R06AX27

ATC

desloratadine; oral

1.5

14.2

685

5204

J01DA06

ATC

[U] cefuroxime

1.7

14.2

292

1831

J46

ICD-10 Finland

Status asthmaticus

2.8

14.2

254

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

14.2

510

3652

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

14.2

618

4604

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

14.1

214

1229

C10AC01

ATC

colestyramine; oral

2.9

14.1

227

AA1BG, ,

SPAT

2.9

14.1

227

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

14.0

146

739

S22.3

ICD-10 Finland

Fracture of rib

2.0

14.0

149

760

A29

ICPC

General symptom/complaint other

1.7

14.0

250

1507

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.9

14.0

J01MA14

ATC

moxifloxacin; systemic

1.9

14.0

174

938

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

14.0

150

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

3.4

14.0

150

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.9

14.0

103

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

13.9

461

3240

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

13.9

396

2691

SPAT1240

SPAT

Therapeutic discussion

1.7

13.9

270

1667

R07.0

ICD-10 Finland

Pain in throat

1.9

13.9

189

1050

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

13.9

126

606

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

13.9

199

1124

J01CA04

ATC

amoxicillin; systemic

1.6

13.8

1767

16056

R09

ICPC

Sinus symptom/complaint

1.8

13.8

216

1254

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

13.7

148

759

R03BA02

ATC

budesonide; inhalant

1.6

13.7

377

2540

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

13.7

147

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

13.7

574

4237

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

13.7

196

1107

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

13.6

259

1589

J45.8

ICD-10 Finland

Mixed asthma

2.8

13.6

254

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.5

13.6

336

R00.2

ICD-10 Finland

Palpitations

1.9

13.6

192

1080

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.1

13.5

184

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

13.5

174

D09

ICPC

Nausea

2.1

13.5

123

593

N02AJ13

ATC

tramadol and paracetamol; systemic

3.1

13.4

190

SFA30

NOMESCO Finland

Three-surface restoration

1.4

13.4

878

7042

F01

ICPC

Eye pain

2.5

13.2

322

J01MA12

ATC

levofloxacin; systemic

1.6

13.2

310

2008

L04

ICPC

Chest symptom/complaint

2.0

13.2

144

742

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

13.1

198

1135

PA2AD

NOMESCO Finland

CT angiography of brain

4.4

13.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

13.1

447

3159

K80

ICPC

Cardiac arrhythmia NOS

1.9

13.1

164

887

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

13.0

1505

13299

S80.0

ICD-10 Finland

Contusion of knee

1.8

12.9

186

1051

C07AB03

ATC

atenolol; systemic

2.5

12.9

320

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.3

12.9

153

N06AX05

ATC

trazodone; oral

2.7

12.9

256

M01AE51

ATC

ibuprofen, combinations; systemic

4.1

12.8

L05

ICPC

Flank/axilla symptom/complaint

2.0

12.8

138

708

XQ800

NOMESCO Finland

Prick test

1.8

12.8

184

1040

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

12.8

257

TAB20

NOMESCO Finland

Epidural puncture

5.4

12.8

K04.08

ICD-10 Finland

Other specified pulpit

1.8

12.8

221

1320

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

12.7

396

SPAT1260

SPAT

Consultation of another employee

1.6

12.7

315

2067

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

12.7

212

1252

EB1VA, ,

NOMESCO Finland

1.5

12.7

402

2792

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

12.7

124

613

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

12.7

409

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

12.7

146

766

K11.2

ICD-10 Finland

Sialoadenitis

2.5

12.7

323

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

12.6

555

4124

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

12.6

263

1652

A99

ICPC

Disease/condition unspecnature/site

1.8

12.6

208

1225

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

12.6

155

833

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

12.6

220

1318

U02

ICPC

Urinary frequency/urgency

1.7

12.5

278

1775

ZXD05

NOMESCO Finland

Urgent procedure

1.5

12.5

593

4470

R63.4

ICD-10 Finland

Abnormal weight loss

2.5

12.5

319

B01AB05

ATC

enoxaparin; parenteral

1.5

12.5

525

3867

R83

ICPC

Respiratory infection other

1.4

12.5

643

4923

N07CA01

ATC

betahistine; oral

2.1

12.5

118

577

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

5.0

12.4

A07AA02

ATC

nystatin; oral

2.2

12.4

100

459

M76.0

ICD-10 Finland

Gluteal tendinitis

2.8

12.4

216

R06.2

ICD-10 Finland

Wheezing

2.2

12.4

105

492

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

12.3

297

G03DC03

ATC

lynestrenol; oral

2.8

12.3

211

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

12.3

250

1561

WYA10

NOMESCO Finland

Emergency care or similar visit

1.9

12.3

166

920

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

12.2

116

568

N06BA04

ATC

methylphenidate; oral

2.1

12.2

115

562

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

12.2

218

N03

ICPC

Pain face

4.4

12.2

A01AB09

ATC

miconazole; local oral

1.9

12.1

147

786

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

12.1

282

1824

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

12.1

631

4839

A02BA03

ATC

famotidine; systemic

2.9

12.0

197

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

12.0

152

824

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.8

12.0

M54

ICD-10 Finland

Dorsalgia

1.6

11.9

294

1926

UJH02

NOMESCO Finland

Anoscopy

2.4

11.9

351

WX892

NOMESCO Finland

Monitored bed care

2.0

11.9

134

698

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

11.9

140

741

SFA20

NOMESCO Finland

Two-surface restoration

1.4

11.9

1292

11195

OAB93, ,

SPAT

1.7

11.9

204

1216

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

11.8

223

1363

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

11.8

448

F41.00

ICD-10 Finland

Moderate panic disorder

2.9

11.8

199

XA402

NOMESCO Finland

ENMG

2.8

11.8

222

L13

ICPC

Hip symptom/complaint

1.6

11.8

316

2113

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

11.7

216

1312

J20

ICD-10 Finland

Acute bronchitis

1.7

11.7

222

1359

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

11.7

483

3538

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.6

11.7

263

A28

ICPC

Limited function/disability NOS

1.7

11.7

216

1314

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

11.6

489

3595

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

11.6

558

4208

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.6

11.6

247

C01DA14

ATC

isosorbide mononitrate; oral

1.9

11.6

144

777

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

11.5

210

1272

KMAK, ,

NOMESCO Finland

1.4

11.5

1115

9459

L16

ICPC

Ankle symptom/complaint

1.6

11.5

260

1667

R03AC13

ATC

formoterol; inhalant

2.2

11.5

447

F43.00

ICD-10 Finland

Acute stress reaction mild

2.4

11.5

326

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.9

11.5

186

SGA01

NOMESCO Finland

Emergency treatment

1.5

11.4

399

2825

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

11.4

215

1314

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

11.4

137

731

R03BA08

ATC

ciclesonide; inhalant

1.8

11.3

189

1116

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

11.3

185

1086

R03AC12

ATC

salmeterol; inhalant

2.4

11.3

316

N02CA72

ATC

ergotamine, combinations with psycholeptics; oral

15.1

11.3

B01AC04

ATC

clopidogrel; oral

1.7

11.3

200

1203

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

3.4

11.3

115

SPAT1312

SPAT

General health counselling

1.4

11.3

609

4688

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

11.2

755

6034

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

11.2

446

IHZ05, ,

SPAT

2.0

11.1

127

666

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

11.0

119

611

F45.0

ICD-10 Finland

Somatization disorder

5.8

11.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

11.0

579

4432

SPAT1097

SPAT

Recording of ECG

1.7

11.0

218

1351

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.3

11.0

352

XKC03

NOMESCO Finland

Water cystometry

2.8

10.9

191

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

10.9

281

1858

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

10.9

133

712

K04

ICPC

Palpitations/awareness of heart

2.0

10.9

112

565

R30.0

ICD-10 Finland

Dysuria

2.1

10.9

104

511

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

10.9

128

678

R60.0

ICD-10 Finland

Localized oedema

1.7

10.8

205

1254

R75

ICPC

Sinusitis acute/chronic

2.0

10.8

123

643

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

10.8

472

U05

ICPC

Urination problems other

2.2

10.8

393

C08CA05

ATC

nifedipine; systemic

2.2

10.8

406

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

10.8

841

6870

SPAT1252

SPAT

Overall medication plan or its review

2.1

10.8

466

R12

ICD-10 Finland

Heartburn

1.7

10.8

184

1095

L29

ICPC

Musculoskeletal sympt/complt other

1.8

10.7

175

1028

NB3AA

NOMESCO Finland

Clavicle X-ray examination

3.4

10.7

114

ZXD35

NOMESCO Finland

Usual procedure

2.5

10.6

258

K04.09

ICD-10 Finland

Pulpit UNS

2.0

10.6

122

641

A02BC04

ATC

rabeprazole; oral

1.7

10.6

185

1107

N06AA06

ATC

trimipramine; systemic

2.7

10.6

200

H02.4

ICD-10 Finland

Ptosis of eyelid

2.6

10.6

223

P74

ICPC

Anxiety disorder/anxiety state

1.9

10.6

136

742

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

10.6

476

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

10.6

235

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.6

10.5

234

1493

C10AA05

ATC

atorvastatin; oral

1.4

10.5

619

4824

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

10.5

484

AA1CG, ,

SPAT

3.6

10.5

A04AA01

ATC

ondansetron; systemic, rectal

1.8

10.5

151

854

M54.8

ICD-10 Finland

Other dorsalgia

2.1

10.5

102

505

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

10.5

237

1520

F29

ICPC

Eye symptom/complaint other

1.7

10.4

213

1330

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

10.4

215

1346

M22.4

ICD-10 Finland

Chondromalacia patellae

2.2

10.4

373

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

10.4

120

631

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

10.4

141

783

SPAT1153

SPAT

Removal of sutures

1.4

10.3

505

3809

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.7

10.3

215

1350

M01AX01

ATC

nabumetone; oral

2.4

10.3

305

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

10.3

167

979

ZXD20

NOMESCO Finland

Day surgery

1.6

10.3

237

1527

J01FA15

ATC

telithromycin; oral

1.7

10.2

201

1242

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

10.2

140

779

J01CA08

ATC

pivmecillinam; oral

1.4

10.2

769

6232

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.2

10.2

396

Z50.1

ICD-10 Finland

Other physical therapy

2.1

10.2

456

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

10.2

416

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

7.5

10.2

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

10.2

206

1284

Z72.0

ICD-10 Finland

Tobacco use

2.4

10.2

276

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

10.1

189

1152

K04.00

ICD-10 Finland

Hyperemia of pulp

1.9

10.1

125

673

R29

ICPC

Respiratory symptom/complaint other

1.8

10.1

147

834

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

10.1

121

645

JAH01

NOMESCO Finland

Laparoscopy

2.0

10.1

104

526

N05AH03

ATC

olanzapine; systemic

1.8

10.1

152

872

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

10.1

167

985

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.7

10.1

207

1295

NA1BG, ,

SPAT

2.6

10.1

235

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

10.0

121

646

G44.3

ICD-10 Finland

Chronic post-traumatic headache

14.6

10.0

N05AA02

ATC

levomepromazine; systemic

2.2

10.0

406

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

9.9

151

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

9.9

285

P25

ICPC

Phase of life problem adult

2.0

9.9

114

599

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

9.9

368

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

9.8

288

1961

A85

ICPC

Adverse effect medical agent

3.6

9.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

9.8

181

1100

E0000UV, ,

ATC

1.3

9.8

823

6772

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.6

9.8

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.7

9.8

203

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.8

9.8

169

R35

ICD-10 Finland

Polyuria

1.9

9.8

118

631

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

9.7

168

1002

N02AC04

ATC

dextropropoxyphene; oral

2.7

9.7

192

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

9.7

174

1049

N06AX17

ATC

milnacipran; oral

3.7

9.7

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

9.7

198

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.1

9.7

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

9.7

155

905

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

9.6

379

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

9.6

130

721

C03CA01

ATC

furosemide; systemic

1.5

9.6

323

2264

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.4

9.6

265

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

9.6

214

1367

H15.1

ICD-10 Finland

Episcleritis

2.9

9.6

149

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

9.5

172

1039

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

9.5

348

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

9.5

329

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

9.5

503

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.6

9.5

218

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

9.5

236

D07AD01

ATC

clobetasol; topical

1.5

9.5

304

2110

L15

ICPC

Knee symptom/complaint

1.4

9.5

469

3540

J01DC02

ATC

cefuroxime; systemic

1.9

9.4

118

638

SPAT1058

SPAT

PEF monitoring instruction

1.8

9.4

132

740

A97

ICPC

No disease

1.5

9.4

380

2762

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.2

9.4

337

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

9.4

131

734

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

9.3

162

969

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

9.3

187

1163

M01AB08

ATC

etodolac; oral

1.8

9.3

126

700

R31

ICD-10 Finland

Unspecified haematuria

1.8

9.3

141

811

J01DA09

ATC

[U] cefadroxil

1.4

9.3

515

3963

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

9.3

480

H81.0

ICD-10 Finland

Ménière disease

2.9

9.2

141

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

9.2

508

R39.1

ICD-10 Finland

Other difficulties with micturition

2.6

9.2

215

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

9.2

159

949

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

9.2

334

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.7

9.2

175

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

13.7

9.2

M01AG01

ATC

mefenamic acid; oral

2.4

9.2

252

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

9.2

252

S16

ICPC

Bruise/contusion

2.5

9.1

228

A62

ICPC

General and Unspecified, Administrative procedure

2.7

9.1

187

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

9.1

428

N81.6

ICD-10 Finland

Rectocele

2.0

9.1

102

532

R01AD05

ATC

budesonide; nasal

1.7

9.1

152

899

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

2.2

9.1

329

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

9.1

229

T74.1

ICD-10 Finland

Physical abuse

2.5

9.1

223

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

9.0

127

713

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

9.0

112

604

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

9.0

192

1211

-1, ,

NOMESCO Finland

1.3

9.0

702

5695

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

9.0

370

D19

ICPC

Teeth/gum symptom/complaint

1.4

8.9

662

5327

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.3

8.9

280

R01AD11

ATC

triamcinolone; nasal

1.7

8.9

169

1035

I20.09

ICD-10 Finland

Unstable angina

2.2

8.9

345

R01

ICPC

Pain respiratory system

2.7

8.9

178

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

8.9

113

615

EMB10

NOMESCO Finland

Tonsillectomy

1.7

8.9

147

867

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.6

8.8

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

8.8

202

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.8

8.8

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

8.8

583

4612

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

8.8

113

618

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

8.7

107

575

C08DB01

ATC

diltiazem; oral

2.5

8.7

209

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

8.7

143

841

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.8

8.7

123

692

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.1

8.7

119

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.4

8.7

234

R52.0

ICD-10 Finland

Acute pain

2.1

8.7

382

D10

ICPC

Vomiting

1.7

8.7

153

919

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.0

8.7

499

WX400

NOMESCO Finland

Inhalation anesthesy

2.1

8.6

417

H02BX01

ATC

methylprednisolone, combinations; systemic

2.3

8.6

285

N06AB05

ATC

paroxetine; oral

1.8

8.6

126

718

X15

ICPC

Vaginal symptom/complaint other

1.9

8.5

104

558

UJD02

NOMESCO Finland

Gastroscopy

2.1

8.5

391

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

8.5

139

816

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

8.5

149

893

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

8.5

164

1009

H93.1

ICD-10 Finland

Tinnitus

1.8

8.5

137

802

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.5

710

5809

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

8.5

207

1351

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

8.5

100

531

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

8.5

140

826

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

8.5

413

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

8.4

136

796

A01AB04

ATC

amphotericin B; local oral

2.2

8.4

307

R33

ICD-10 Finland

Retention of urine

1.9

8.4

504

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

90.4

8.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

8.4

227

1516

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.3

8.4

269

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

8.4

149

897

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.7

8.4

155

R04

ICPC

Breathing problem other

2.1

8.4

374

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

8.4

148

890

WX704

NOMESCO Finland

Intubation

1.7

8.3

152

921

R01AD01

ATC

beclometasone; nasal

1.5

8.3

304

2164

F34.1

ICD-10 Finland

Dysthymia

2.0

8.3

471

G01AF05

ATC

econazole; vaginal

1.7

8.3

149

899

S21

ICPC

Skin texture symptom/complaint

1.5

8.3

267

1852

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.2

8.3

296

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.2

8.3

309

WZC30

NOMESCO Finland

Teaching

1.5

8.3

287

2022

EBA00

NOMESCO Finland

Extraction of tooth

1.3

8.3

740

6108

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

8.3

116

652

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.9

8.2

529

SPAT1360

SPAT

Extensive global examination

1.9

8.2

105

573

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

8.2

144

864

B37.08

ICD-10 Finland

Other candidal stomatitis

4.2

8.2

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

8.2

446

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

8.2

364

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

8.2

139

827

J02AC02

ATC

itraconazole; systemic

1.5

8.2

316

2275

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.1

8.1

392

SGC10

NOMESCO Finland

Pulp capping

1.6

8.1

211

1398

E22.1

ICD-10 Finland

Hyperprolactinaemia

3.5

8.1

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.3

8.1

267

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

8.1

193

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.3

8.1

N92

ICPC

Trigeminal neuralgia

11.7

8.1

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

8.1

116

657

L20

ICPC

Joint symptom/complaint NOS

2.0

8.0

407

A06AC51

ATC

ispaghula, combinations; oral

2.0

8.0

421

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

8.0

170

F03

ICPC

Eye discharge

1.7

8.0

141

846

N39.3

ICD-10 Finland

Stress incontinence

1.8

8.0

125

725

H02AB09

ATC

hydrocortisone; systemic

2.4

8.0

212

SBA00

NOMESCO Finland

Microbiological examinations

2.4

8.0

212

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

8.0

182

N30.2

ICD-10 Finland

Other chronic cystitis

4.1

8.0

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.9

8.0

120

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

8.0

131

772

Z01.7

ICD-10 Finland

Laboratory examination

1.4

8.0

327

2380

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

8.0

341

DHB50

NOMESCO Finland

Turbinoplasty

2.2

7.9

295

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.1

7.9

382

K92.1

ICD-10 Finland

Melaena

2.1

7.9

362

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.6

7.9

166

SPAT1229

SPAT

Assessment of need for aid

1.9

7.9

516

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

7.9

105

ZXA00

NOMESCO Finland

Right side

1.4

7.9

386

2900

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

7.9

110

618

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

7.8

115

655

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

7.8

352

2603

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

7.8

474

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.6

7.8

202

1336

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.4

7.8

227

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.1

7.8

SPAT1106

SPAT

Acupuncture

4.1

7.8

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.1

7.8

337

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.4

7.8

221

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

7.8

278

1969

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.9

7.8

475

R518, ,

ICD-10 Finland

7.0

7.8

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

7.8

272

R07.1

ICD-10 Finland

Chest pain on breathing

2.8

7.7

139

N76.0

ICD-10 Finland

Acute vaginitis

1.6

7.7

167

1059

M02AA10

ATC

ketoprofen; topical

1.5

7.7

255

1779

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

3.9

7.7

M50

ICD-10 Finland

Cervical disc disorders

3.9

7.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

7.7

237

1629

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

7.7

133

795

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.6

7.7

174

D07AC01

ATC

betamethasone; topical

1.3

7.7

668

5480

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

7.4

7.7

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

7.7

138

834

SPAT1216

SPAT

Assessment of functional ability

1.6

7.7

194

1277

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.7

7.7

151

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

7.6

185

1205

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.9

7.6

493

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

7.6

211

G93.3

ICD-10 Finland

Postviral fatigue syndrome

4.0

7.6

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.9

7.6

118

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.8

7.6

129

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

7.6

301

R04.2

ICD-10 Finland

Haemoptysis

2.4

7.6

224

N20.1

ICD-10 Finland

Calculus of ureter

2.1

7.6

321

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

7.6

221

1502

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

7.6

106

596

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.7

7.5

141

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.7

7.5

141

WVA20, ,

SPAT

2.1

7.5

349

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.1

7.5

329

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

2.8

7.5

130

L60.0

ICD-10 Finland

Ingrowing nail

1.8

7.5

547

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

7.5

187

1228

P02

ICPC

Acute stress reaction

1.7

7.5

147

910

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

7.5

136

825

H57.0

ICD-10 Finland

Anomalies of pupillary function

3.9

7.4

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

7.4

105

592

UJD10, ,

SPAT

2.3

7.4

227

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

7.4

104

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

3.0

7.4

104

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.0

7.4

400

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

7.4

458

3574

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

7.3

550

R06AE09

ATC

levocetirizine; oral

1.4

7.3

302

2197

OAA65, ,

SPAT

1.3

7.3

507

4023

R20.0

ICD-10 Finland

Anaesthesia of skin

3.5

7.3

J01

ICD-10 Finland

Acute sinusitis

1.7

7.3

133

808

J05AB11

ATC

valaciclovir; oral

1.5

7.2

270

1928

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

7.2

231

1600

3461A

ICD-9 Finland

Migraine, Common migraine

15.8

7.2

L10

ICPC

Elbow symptom/complaint

1.7

7.2

124

740

O20.0

ICD-10 Finland

Threatened abortion

2.2

7.2

274

C10AX09

ATC

ezetimibe; oral

1.5

7.2

252

1777

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.9

7.2

424

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

7.2

410

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

7.3

7.2

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.8

7.2

108

621

XJH00

NOMESCO Finland

Transanal ultrasonography

2.1

7.1

302

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.9

7.1

447

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

7.1

200

1348

L07

ICPC

Jaw symptom/complaint

2.6

7.1

157

G02CB01

ATC

bromocriptine; systemic

2.5

7.1

181

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.2

7.1

276

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

7.9

7.1

N04BC09

ATC

rotigotine; transdermal

7.9

7.1

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

7.1

104

593

PA2CG, ,

SPAT

4.1

7.1

R08

ICPC

Nose symptom/complaint other

1.9

7.1

420

SPAT1310

SPAT

Counselling related to known health issue

1.3

7.0

562

4545

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

7.0

132

807

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

7.0

238

R03DA04

ATC

theophylline; systemic, rectal

2.1

7.0

324

SPAT1377

SPAT

Polysomnography

2.1

7.0

304

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.8

7.0

118

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

3.2

7.0

R07.2

ICD-10 Finland

Precordial pain

2.6

7.0

147

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

6.9

202

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.1

6.9

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.1

6.9

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

6.9

424

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.1

6.9

300

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

6.9

240

1693

EC1VA, ,

NOMESCO Finland

1.8

6.8

548

L11

ICPC

Wrist symptom/complaint

1.5

6.8

195

1319

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

8.3

6.8

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.9

6.8

490

R06AX26

ATC

fexofenadine; oral

1.6

6.8

151

964

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

11.0

6.8

TNX00, ,

SPAT

2.7

6.8

126

G04BD08

ATC

solifenacin; oral

1.9

6.8

455

H03AA01

ATC

levothyroxine sodium; systemic

1.4

6.8

391

3013

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.3

6.7

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

3.6

6.7

C08CA06

ATC

nimodipine; systemic

16.7

6.7

S01

ICPC

Pain/tenderness of skin

1.9

6.7

463

K12.18

ICD-10 Finland

Other forms of stomatitis

3.9

6.7

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

6.7

224

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

6.7

303

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

3.3

6.7

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

6.7

162

K05.0

ICD-10 Finland

Acute gingivitis

2.2

6.7

250

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

6.7

379

G51.8

ICD-10 Finland

Other disorders of facial nerve

22.6

6.7

G03DB01

ATC

dydrogesterone; oral

1.5

6.7

244

1736

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

6.7

201

1376

M70.7

ICD-10 Finland

Other bursitis of hip

2.4

6.6

187

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.2

6.6

251

PD5AD

NOMESCO Finland

CT of aorta

2.4

6.6

175

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

6.6

169

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.2

6.6

232

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.6

6.6

N30.8

ICD-10 Finland

Other cystitis

3.6

6.6

A92

ICPC

Allergy/allergic reaction NOS

1.9

6.6

409

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

6.6

213

1479

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

6.6

353

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.4

6.6

188

S70

ICPC

Herpes zoster

2.4

6.6

188

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.6

6.6

134

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.2

6.6

239

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.4

6.6

PAW37

NOMESCO Finland

Biopsy of temporal artery

8.7

6.5

M01AH03

ATC

valdecoxib; oral

1.8

6.5

563

R06.5

ICD-10 Finland

Mouth breathing

1.6

6.5

171

1135

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.4

6.5

252

1811

H15.0

ICD-10 Finland

Scleritis

6.9

6.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

6.5

505

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.0

6.5

341

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

6.5

184

1243

SPAT1044

SPAT

Tympanometry

2.4

6.5

183

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.1

6.5

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

2.0

6.5

314

C08CA01

ATC

amlodipine; oral

1.3

6.5

511

4121

L09

ICPC

Arm symptom/complaint

1.8

6.5

101

588

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.6

6.5

159

1041

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.5

6.4

165

N94.1

ICD-10 Finland

Dyspareunia

2.5

6.4

159

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.2

6.4

254

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.2

6.4

254

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.2

6.4

R06AX13

ATC

loratadine; oral

1.4

6.4

308

2301

JEA00

NOMESCO Finland

Appendectomy

1.7

6.4

122

750

C10AA07

ATC

rosuvastatin; oral

1.3

6.4

539

4384

SFA00

NOMESCO Finland

Small restoration

1.4

6.3

268

1958

J04.0

ICD-10 Finland

Acute laryngitis

1.8

6.3

487

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

6.3

145

933

IGY02, ,

SPAT

2.4

6.3

185

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

6.3

213

1491

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

2.8

6.3

108

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.6

6.3

M75.8

ICD-10 Finland

Other shoulder lesions

1.8

6.3

466

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

6.3

459

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

6.3

150

975

3460A

ICD-9 Finland

Migraine, Classical migraine

9.3

6.3

T91.8

ICD-10 Finland

Sequelae of other specified injuries of neck and trunk

9.3

6.3

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

6.3

571

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

6.2

127

794

F32

ICD-10 Finland

Depressive episode

1.6

6.2

124

771

R06.4

ICD-10 Finland

Hyperventilation

2.6

6.2

132

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.9

6.2

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

2.5

6.2

144

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

3.7

6.2

ZA6.0

ICD-10 Finland

Lower leg

3.1

6.2

L04AX03

ATC

methotrexate; systemic

1.5

6.2

175

1183

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.2

6.2

239

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

6.2

381

2964

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.0

6.1

334

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

6.1

229

1635

R49.08

ICD-10 Finland

Other specified dysphonia

2.3

6.1

194

S10

ICPC

Boil/carbuncle

1.7

6.1

112

681

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

6.1

106

635

N64.4

ICD-10 Finland

Mastodynia

1.9

6.1

398

U06

ICPC

Haematuria

2.5

6.1

151

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

6.1

560

G04BD12

ATC

mirabegron; oral

1.6

6.1

153

1006

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

6.1

175

1186

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

6.1

107

644

TAC99

NOMESCO Finland

Other blockade for chronic pain

3.8

6.1

4211

FHL

Transeptal septal resection and reconstruction

4.1

6.1

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.0

6.1

294

K29.1

ICD-10 Finland

Other acute gastritis

3.0

6.1

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

6.1

142

919

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

6.1

170

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

6.1

421

R78

ICPC

Acute bronchitis/bronchiolitis

2.4

6.1

164

R03BB01

ATC

ipratropium bromide; inhalant

2.3

6.0

189

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.5

6.0

152

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

2.5

6.0

152

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.1

6.0

261

C05AA08

ATC

fluocortolone; rectal, topical

1.5

6.0

210

1480

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.1

6.0

268

N05BE01

ATC

buspirone; oral

2.0

6.0

309

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

6.0

316

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

901

5091

2.33

75.74

2.7

2.2

127.33

236.23

u/l

3.17

868

4868

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1204

8215

2.06

57.25

6.8

7.1

1.21

mmol/l

0.57

1075

7162

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1096

7297

2.03

54.99

6.3

6.5

1.21

mmol/l

0.02

1045

6816

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

757

4420

2.10

54.41

2.0

1.8

0.84

0.98

mg/l

0.77

569

3343

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1721

13747

2.27

49.91

5.4

4.2

9.05

9.89

mm/h

2.55

1658

13032

(3013826) Glucose [Moles/volume] in Serum or Plasma

1393

10327

1.99

48.87

6.1

5.0

6.20

6.53

mmol/l

10.64

1346

9675

(3036481) Cortisol [Moles/volume] in Serum or Plasma

412

1959

2.37

48.57

2.3

2.2

352.36

374.38

nmol/l

1.67

391

1837

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

680

4003

2.02

46.33

1.5

1.3

24.22

25.52

iu/ml

0.11

197

1162

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

879

5712

1.91

44.39

3.5

2.7

53.89

58.82

u/l

2.69

837

5349

(3006315) Basophils [#/volume] in Blood

1324

9842

1.90

43.70

6.5

6.6

0.04

e9/l

0.00

1189

8585

(3019198) Lymphocytes [#/volume] in Blood

1349

10093

1.91

43.59

6.5

6.6

2.03

1.97

e9/l

0.86

1235

9027

(3018418) pH of Serum or Plasma

780

4896

1.93

43.55

3.6

4.1

7.39

7.40

0.52

570

3429

(3024561) Albumin [Mass/volume] in Serum or Plasma

1074

7479

1.87

43.43

5.0

5.1

36.94

36.68

g/l

0.84

1017

7081

(3001604) Monocytes [#/volume] in Blood

1321

9828

1.89

43.30

6.5

6.6

0.56

e9/l

0.03

1186

8581

(3013115) Eosinophils [#/volume] in Blood

1352

10159

1.89

42.68

6.6

6.8

0.19

e9/l

0.13

1232

9019

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

928

6197

1.88

42.58

4.4

3.1

32.47

54.31

ng/l

0.79

534

3677

(3018010) Neutrophils/Leukocytes in Blood

1246

9156

1.86

41.83

6.5

56.24

56.67

0.72

1213

8802

(3031040) Bacteria [#/volume] in Urine by Automated count

1502

11755

1.92

40.90

6.0

4.1

216.07

1137.40

e6/l

1.25

138

(3013650) Neutrophils [#/volume] in Blood by Automated count

1415

10863

1.89

40.90

9.0

9.7

4.06

4.03

e9/l

0.24

1274

9535

(3002030) Lymphocytes/Leukocytes in Blood

1255

9301

1.84

40.36

6.7

6.6

29.35

28.84

0.98

1217

8884

(3019069) Monocytes/Leukocytes in Blood

1224

9008

1.83

40.21

6.7

8.34

8.60

2.94

1182

8520

(3015377) Calcium [Moles/volume] in Serum or Plasma

875

5816

1.85

40.06

2.8

3.4

2.35

mmol/l

0.52

811

5402

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

616

3658

1.96

39.89

1.4

1.3

6.02

10.35

u/ml

1.66

240

1523

(3006504) Eosinophils/Leukocytes in Blood

1220

8987

1.83

39.77

6.6

2.73

2.82

0.93

1180

8485

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1689

13846

2.03

38.93

9.3

8.0

75.91

75.67

u/l

0.07

1634

13260

(3022096) Basophils/Leukocytes in Blood

1215

8977

1.81

38.82

6.8

6.7

0.69

0.05

1172

8465

(3032080) INR in Blood by Coagulation assay

1024

7211

1.80

38.23

10.6

10.7

1.13

1.15

inr

0.72

869

5960

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1241

9286

1.80

37.40

7.0

6.5

9.58

11.03

umol/l

7.74

1184

8882

(3018095) Leukocytes [#/volume] in Urine

948

6638

1.77

35.13

4.8

3.6

40.49

75.33

e6/l

2.33

693

4513

(3002582) Erythrocytes [#/volume] in Urine

826

5562

1.79

34.98

4.0

3.1

61.70

65.07

e6/l

0.03

638

4182

(40768797) Stomach Pathology biopsy report

454

2527

2.01

34.79

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

520

3052

1.93

34.07

1.6

1.4

474.69

499.42

titre

0.11

620

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

299

1433

2.26

33.76

2.5

2.4

19.41

20.31

au/ml

0.07

182

(36304419) Bacteria [Presence] in Urine

712

4640

1.80

33.31

3.6

2.8

—

0.00

estimate

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1016

7356

1.72

32.65

2.3

2.0

96.82

97.41

pmol/l

0.15

573

4081

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

279

1338

2.25

31.34

1.4

1.3

46.89

45.43

au/ml

0.04

(3021601) Nitrite [Presence] in Urine by Test strip

1275

9890

1.71

31.23

4.5

3.4

0.00

estimate

0.80

269

2053

(3048689) Calprotectin [Mass/mass] in Stool

489

2896

1.89

30.78

2.6

2.7

108.49

117.23

ug/g

0.22

407

2346

(3035350) Ketones [Presence] in Urine by Test strip

1282

9991

1.70

30.55

4.5

3.5

18.23

6.05

estimate

0.57

275

2066

(3030467) Casts [#/volume] in Urine by Automated count

719

4794

1.75

30.53

3.8

2.9

0.29

0.37

e6/l

0.66

526

3442

(3018677) aPTT in Platelet poor plasma by Coagulation assay

437

2501

1.94

30.48

2.4

2.2

29.17

29.34

0.27

423

2435

(3009261) Glucose [Presence] in Urine by Test strip

1285

10040

1.70

30.14

4.6

3.5

0.00

0.16

estimate

0.54

263

1946

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1758

15042

1.93

29.88

5.6

4.4

14.53

14.49

pmol/l

0.32

1687

14134

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

145

520

2.92

29.88

1.4

1.3

414.78

507.18

mg/l

3.08

140

493

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

756

5150

1.72

29.51

1.4

1.3

0.96

1.60

u/ml

2.06

230

1516

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

132

455

3.03

29.18

1.4

219.68

1570.56

e6/l

1.15

102

355

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2050

18706

3.12

28.78

20.6

13.3

18.26

21.56

mg/l

6.04

1771

15175

(3021960) Folate [Moles/volume] in Serum or Plasma

675

4484

1.74

28.67

1.8

1.6

19.28

20.23

nmol/l

1.10

599

3948

(3015736) pH of Urine

1070

8034

1.66

28.63

3.9

3.1

6.19

0.03

617

4698

(3033658) Prothrombin time (PT) actual/Normal

686

4587

1.73

28.41

5.3

4.0

95.28

93.77

0.95

668

4486

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

129

447

3.01

28.25

1.4

3.63

14.68

e6/l

2.39

332

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

685

4593

1.72

28.01

2.7

2.2

2.53

2.67

mg/l

0.95

609

4014

(3000850) Epithelial cells [#/volume] in Urine

582

3760

1.75

27.00

3.0

2.6

5.89

6.44

e6/l

0.41

528

3421

(3044290) Cell count panel - Cerebral spinal fluid

123

426

3.00

26.96

1.3

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

468

2841

1.83

26.79

3.1

3.7

0.83

0.82

mmol/l

0.42

446

2710

(3019550) Sodium [Moles/volume] in Serum or Plasma

2028

18514

2.72

26.30

21.1

14.5

139.71

139.65

mmol/l

0.63

2008

18174

(3023103) Potassium [Moles/volume] in Serum or Plasma

2032

18569

2.76

26.28

21.2

14.6

3.94

mmol/l

0.64

2011

18191

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1108

8508

1.62

26.22

2.9

2.5

76.25

74.50

nmol/l

1.13

1037

7932

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

498

3109

1.78

25.86

4.7

3.5

355.82

500.23

ng/l

0.50

297

2065

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

919

6769

1.63

25.56

3.9

3.4

27.34

33.97

u/l

2.07

890

6426

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

326

1795

1.96

25.08

2.9

2.6

32.20

67.81

u/l

0.73

282

1528

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

444

2715

1.80

24.58

3.5

2.7

4.14

2.87

e6/l

0.71

223

1269

(3007164) IgA [Mass/volume] in Serum or Plasma

653

4456

1.67

24.32

1.6

1.5

2.15

2.30

g/l

1.63

424

2972

(3023368) Bacteria identified in Blood by Culture

634

4305

1.67

24.01

4.7

4.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

487

3078

1.75

24.01

2.5

2.7

2.42

2.43

mmol/l

0.58

437

2785

(3026782) Osmolality of Urine

502

3201

1.74

23.99

3.0

2.7

534.47

533.93

mosm/kgh2o

0.02

438

2817

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

125

467

2.78

23.86

1.3

1.2

3.63

3.69

mmol/l

0.26

116

439

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

425

2601

1.79

23.34

2.2

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1938

17498

2.10

23.33

6.9

5.3

1.67

1.80

mu/l

6.55

1870

16595

(3026008) Bacteria identified in Urine by Culture

679

4736

1.63

22.94

3.3

2.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

134

531

2.62

22.79

1.5

1.4

294.45

301.51

ug/g

0.12

290

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

466

2953

1.74

22.60

3.4

2.6

0.96

0.99

e6/l

0.07

253

1496

(3005719) IgG [Mass/volume] in Serum or Plasma

287

1566

1.96

22.54

2.1

2.9

9.68

10.66

g/l

6.10

269

1461

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

693

4880

1.62

22.42

1.9

1.6

—

(3023410) Appearance of Cerebral spinal fluid

204

3.62

21.84

1.3

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

175

805

2.28

21.49

1.9

1.8

—

(40758558) Short blood count panel - Blood

765

5575

1.58

21.14

5.4

6.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

277

1552

1.90

19.99

1.4

1.3

140.94

290.43

u/ml

1.59

262

1455

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

247

1333

1.96

19.93

1.5

1.4

—

(3019977) pH of Arterial blood

302

1742

1.85

19.90

7.6

9.7

7.43

7.42

1.23

179

960

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

313

1831

1.83

19.71

2.1

1.8

—

(3021589) Normoblasts [#/volume] in Blood

1076

8548

1.52

19.61

11.9

10.4

0.00

e9/l

0.78

897

7025

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

147

653

2.34

19.57

1.8

1.9

0.23

g/l

0.14

142

613

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

323

1912

1.81

19.55

2.1

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

572

3953

1.61

19.49

2.8

3.1

633.96

909.71

ng/l

1.59

458

3272

(3002032) Base excess in Venous blood by calculation

264

1469

1.91

19.44

3.5

1.64

1.80

mmol/l

0.30

236

1269

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1228

10049

1.52

19.32

4.1

3.2

93.74

102.28

ug/l

0.78

1185

9577

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

299

1746

1.83

18.89

7.7

9.7

5.01

5.12

kpa

1.25

292

1692

(3027801) Oxygen [Partial pressure] in Arterial blood

299

1746

1.83

18.89

7.6

9.7

12.34

12.78

kpa

0.78

291

1693

(3016502) Oxygen saturation in Arterial blood

272

1543

1.87

18.85

7.8

10.3

95.76

95.87

0.10

264

1496

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

149

678

2.29

18.76

1.8

1.21

1.20

g/l

0.36

144

637

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1955

17950

2.00

18.70

17.1

12.2

90.62

89.18

ml/min/173m2

2.72

1843

16451

(3003396) Base excess in Arterial blood by calculation

294

1722

1.82

18.37

7.7

9.7

0.98

0.87

mmol/l

0.22

241

1426

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

350

2160

1.74

18.29

2.9

2.8

5.69

7.24

umol/l

1.27

294

1887

(3015171) Extractable nuclear Ab [Units/volume] in Serum

175

868

2.11

17.78

1.3

1.2

0.99

1.11

u/ml

0.05

(3012544) pH of Venous blood

267

1534

1.85

17.73

3.6

7.38

0.31

151

856

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1620

14193

1.58

17.69

4.4

3.3

41.60

43.04

u/l

0.40

1556

13637

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

971

7657

1.49

17.67

4.4

3.3

2.18

0.02

estimate

0.50

233

1711

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

216

3.22

17.31

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

264

1525

1.83

17.21

3.5

5.79

5.84

kpa

0.34

258

1479

(3019309) Folate [Moles/volume] in Red Blood Cells

364

2322

1.68

16.75

1.8

1.7

1132.12

1172.73

nmol/l

0.38

294

1810

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1914

17579

1.82

16.47

5.1

4.4

5.73

5.80

mmol/l

1.84

1820

16558

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

489

3375

1.58

16.34

1.8

1.6

49769993.80

34342486.71

pmol/l

0.21

434

2941

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

267

2.91

16.29

1.4

0.12

0.37

nmol/l

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

402

2651

1.64

16.21

2.5

2.40

2.39

g/l

0.10

380

2479

(3019150) Specific gravity of Urine by Refractometry

600

4358

1.52

15.87

4.4

3.5

1.03

1.72

kg/l

0.79

413

2867

(3022145) Colonoscopy Study observation

335

2120

1.69

15.82

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

238

1369

1.83

15.68

2.9

3.6

4.57

4.59

pmol/l

0.10

217

1244

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1061

8647

1.45

15.57

3.0

2.7

—

estimate

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

249

1461

1.80

15.36

8.5

10.7

126.16

123.78

g/l

0.95

244

1433

(3028707) Methadone [Presence] in Urine by Screen method

123

564

2.25

15.21

2.6

3.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

216

1225

1.85

14.87

1.7

1.9

1.19

1.33

g/l

0.83

202

1148

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

221

3.00

14.79

1.4

0.16

0.26

nmol/l

0.58

163

(3024354) Oxygen [Partial pressure] in Venous blood

222

1278

1.82

14.56

3.1

2.9

4.40

4.65

kpa

1.38

217

1238

(3007853) Bacteria identified in Skin by Aerobe culture

335

2168

1.65

14.43

1.9

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

263

1604

1.73

14.15

1.5

1.4

24.89

24.63

iu/l

0.04

224

1375

(44816559) Phosphatidylethanol [Mass/volume] in Blood

191

1059

1.88

14.11

1.9

1.7

0.25

0.31

mg/l

0.89

510

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

185

3.14

14.05

1.3

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

185

3.14

14.05

1.3

1.2

29.61

40.82

mg/l

2.24

150

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1875

17273

1.67

13.97

6.0

5.4

37.75

38.18

mmol/mol

1.51

1810

16526

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

166

885

1.95

13.79

1.9

2.2

38.31

39.97

u/l

0.53

153

806

(3028192) IgG subclass 2 [Mass/volume] in Serum

209

2.97

13.71

1.3

2.72

3.01

g/l

0.71

146

(3024139) IgG subclass 3 [Mass/volume] in Serum

209

2.97

13.71

1.3

0.32

0.38

g/l

0.81

146

(3027135) IgG subclass 1 [Mass/volume] in Serum

209

2.97

13.71

1.3

5.90

6.64

g/l

1.33

147

(40760892) CBC W Ordered Manual Differential panel - Blood

647

4889

1.46

13.71

5.0

4.6

—

(3036489) Thrombin time

146

750

2.02

13.49

1.7

2.1

20.40

20.45

0.03

121

661

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

245

2.79

13.40

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

369

2.44

13.36

1.3

1.8

0.55

0.75

g/l

1.61

291

(3023420) DNA double strand Ab [Units/volume] in Serum

164

882

1.93

13.28

1.8

2.0

6.68

7.20

iu/ml

0.08

225

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

267

1670

1.68

13.06

1.3

1.2

94.88

141.57

u/ml

1.33

106

641

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2080

19866

2.51

13.03

23.5

16.1

72.72

73.52

umol/l

0.79

2068

19675

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

178

3.09

12.99

1.2

1.1

229.96

250.20

mg/l

0.50

151

(3022948) Iron [Moles/volume] in Serum or Plasma

412

2869

1.54

12.90

2.6

2.5

13.67

14.40

umol/l

1.34

389

2696

(4062490) Immunoglobulin typing, IgG

211

2.90

12.90

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

751

5886

1.42

12.90

2.4

2.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

165

898

1.91

12.90

6.4

8.1

24.34

24.46

mmol/l

0.16

159

862

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

205

1199

1.78

12.73

1.8

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

181

1020

1.85

12.70

3.6

3.3

5.07

5.16

kpa

0.75

174

984

(3000991) Gas panel - Venous blood

225

1354

1.74

12.66

8.4

10.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

735

5756

1.42

12.61

3.9

2.8

0.07

0.06

estimate

0.12

231

1657

(40768804) Tissue Pathology biopsy report

919

7484

1.40

12.57

2.1

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

355

2404

1.57

12.56

2.6

22.96

24.28

1.20

336

2261

(3011288) Drugs identified in Urine by Screen method Nominal

170

946

1.87

12.41

3.1

3.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

158

864

1.89

12.17

3.2

1.37

1.55

mmol/l

0.25

112

629

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

169

947

1.85

12.07

2.2

3.1

94.18

139.10

ng/l

1.38

145

845

(3021387) Prolactin [Units/volume] in Serum or Plasma

195

1144

1.77

11.98

2.2

1.6

285.43

286.82

mu/l

0.02

180

1043

(3028626) Oxygen [Partial pressure] in Capillary blood

363

2.37

11.97

3.0

2.8

8.80

8.34

kpa

1.72

358

(3009343) pH of Capillary blood

174

988

1.83

11.91

3.7

3.3

7.42

7.41

0.48

156

831

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

584

4427

1.44

11.85

2.4

2.2

—

(36660697) Celiac disease serology panel - Serum

268

1719

1.64

11.85

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

311

2.46

11.70

3.7

6.6

328.24

372.29

umol/l

1.58

275

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1590

14292

1.43

11.67

4.1

3.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

220

1346

1.71

11.64

2.8

2.4

0.11

0.34

e6/l

3.80

207

1278

(3013139) Helicobacter pylori Ag [Presence] in Stool

222

1369

1.69

11.41

1.4

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

164

931

1.82

11.24

3.5

24.24

24.25

mmol/l

0.01

164

922

(3004119) Hemoglobin [Mass/volume] in Venous blood

165

941

1.82

11.14

3.3

3.1

133.13

132.77

g/l

0.07

160

914

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

230

2.65

11.01

1.4

—

nmol/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

197

1190

1.72

10.92

1.7

2.8

67.51

67.46

g/l

0.04

188

1121

(3029937) Albumin [Presence] in Urine by Test strip

674

5304

1.39

10.89

4.9

3.6

0.03

0.01

estimate

0.76

265

1939

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

505

3780

1.44

10.84

2.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2067

19815

2.16

10.68

14.3

11.0

27.24

27.29

u/l

0.05

2041

19419

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

466

3445

1.45

10.67

2.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

3.47

10.58

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

199

1220

1.70

10.44

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

175

2.84

10.30

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

159

919

1.79

10.27

9.2

12.0

24.33

24.29

mmol/l

0.07

159

909

(3042936) Bacteria identified in Isolate by Culture

355

2506

1.50

10.24

2.4

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

416

3036

1.46

10.14

2.1

1.8

1.50

1.43

1.39

368

2716

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

201

2.68

9.96

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

121

649

1.92

9.91

1.8

2.3

98.10

94.94

0.78

113

632

(4027681) Cerebrospinal fluid IgG ratio and IgG index

146

2.98

9.90

1.3

0.49

0.61

ratio

3.13

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

3.44

9.88

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

601

4707

1.38

9.80

2.3

2.5

314.06

332.01

umol/l

5.26

539

4252

(3004588) Protein electrophoresis panel - Serum or Plasma

160

942

1.75

9.71

1.6

2.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.44

9.60

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

120

654

1.88

9.38

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

109

3.25

9.32

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

149

870

1.77

9.31

10.4

13.1

16.77

16.25

1.33

143

840

(3015235) Bicarbonate [Moles/volume] in Capillary blood

102

529

1.97

9.23

3.0

2.6

24.90

24.65

mmol/l

0.26

102

524

(3049717) Cytology report of Urine Cyto stain

481

2.02

9.20

2.2

2.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

147

862

1.76

9.06

1.6

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

477

2.02

9.05

1.7

2.3

9.34

10.60

g/l

2.62

441

(3003458) Phosphate [Moles/volume] in Serum or Plasma

306

2150

1.49

8.97

4.7

6.4

1.02

1.04

mmol/l

0.43

287

2021

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1756

16298

1.43

8.96

22.9

16.2

13.42

13.40

0.36

1742

16100

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

529

1.95

8.90

1.7

2.3

2.78

2.88

g/l

0.59

495

(3009214) Lutropin [Units/volume] in Serum or Plasma

142

829

1.76

8.89

1.5

1.4

11.14

9.28

u/l

0.89

123

675

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

167

2.73

8.85

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

173

2.70

8.82

1.2

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

552

1.93

8.82

1.6

2.3

4.19

4.28

g/l

0.54

517

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

552

1.93

8.82

1.6

2.3

7.19

7.21

g/l

0.03

518

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

552

1.93

8.82

1.6

2.3

3.42

3.75

g/l

1.95

518

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

174

2.68

8.73

1.2

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

180

2.65

8.71

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

344

2488

1.46

8.69

2.6

3.2

4.75

4.70

e9/l

0.03

307

2234

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

216

1416

1.58

8.68

2.3

2.6

80.89

74.08

ml/min/173m2

1.95

104

572

(40759836) Histone Ab [Presence] in Serum by Immunoblot

175

2.66

8.63

1.2

1.1

—

(3022621) pH of Urine by Test strip

225

1493

1.57

8.58

2.3

2.1

6.27

6.10

1.65

127

939

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

142

2.85

8.55

1.2

1.05

ratio

0.02

120

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

160

979

1.69

8.47

9.8

12.1

0.66

0.64

0.33

160

974

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

194

1250

1.61

8.38

3.0

3.7

1.22

1.23

mmol/l

0.91

173

1088

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

108

595

1.86

8.19

2.0

2.7

3.62

3.57

g/l

0.11

103

567

(3018333) Ribosomal P Ab [Presence] in Serum

163

2.67

8.14

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

517

1.92

8.14

1.3

1.2

25.90

46.07

u/ml

0.88

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

169

2.64

8.12

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

461

1.97

8.12

5.7

8.1

1.31

1.24

mmol/l

0.27

401

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

146

883

1.70

8.08

1.8

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

262

1822

1.50

8.05

2.5

2.4

13.28

13.32

nmol/l

0.02

246

1695

(3000764) Benzodiazepines [Presence] in Urine

202

1327

1.58

8.05

2.3

—

(3016879) Cocaine [Presence] in Urine

189

1224

1.60

8.00

2.3

2.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

180

1157

1.61

7.86

2.6

2.1

4.95

7.80

ug/l

1.26

153

1047

(3027944) Amphetamines [Presence] in Urine

199

1316

1.56

7.70

2.3

2.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

428

1.98

7.69

1.7

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

3.16

7.69

1.4

1.7

2.07

2.00

umol/l

0.14

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

145

2.72

7.68

1.2

1.1

1.06

1.08

u/l

0.11

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

931

7987

1.29

7.65

1.9

1.45

1.41

mmol/l

0.52

792

6994

(3000494) Fungus identified in Specimen by Culture

325

2380

1.43

7.63

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

108

610

1.81

7.59

1.5

1.3

4.48

9.92

u/ml

0.77

(3008898) HLA-B27 [Presence]

152

947

1.65

7.53

1.1

—

(3045414) Leukocytes [Presence] in Urine

241

1672

1.50

7.48

2.2

2.0

0.06

0.02

estimate

0.27

389

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

482

1.91

7.47

1.3

1.2

4.98

3.99

u/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.09

7.44

9.7

3.2

108.32

125.40

umol/l

0.20

(1002224) Polysomnography panel

192

1270

1.56

7.43

1.1

—

(3022313) Gas panel - Capillary blood

118

689

1.75

7.42

3.8

3.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

107

607

1.80

7.42

1.5

1.2

19.80

2.43

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

135

819

1.69

7.40

1.7

16.33

12.10

u/ml

0.27

218

(3011985) Renin [Units/volume] in Plasma

252

2.25

7.39

1.4

1.5

43.23

72.60

mu/l

0.61

231

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

298

2.15

7.36

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

298

2.15

7.36

1.4

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

240

2.28

7.34

1.4

340.09

386.16

pmol/l

0.38

208

(3028300) Cannabinoids [Presence] in Urine

200

1340

1.54

7.31

2.3

—

(3027008) Opiates [Presence] in Urine

199

1333

1.54

7.28

2.3

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

114

663

1.76

7.27

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

164

1051

1.61

7.26

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.24

7.25

1.1

2.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

175

1145

1.58

7.10

1.1

—

131.41

—

(3025941) Bacteria identified in Stool by Culture

179

1179

1.57

7.06

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

365

2.01

7.02

1.3

1.2

3.69

3.90

u/ml

0.05

127

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.10

7.01

1.1

1.2

0.27

0.29

g/l

0.34

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

278

2.15

6.98

1.3

1.2

2.00

10.63

u/ml

—

(4198724) Urine methamphetamine measurement

130

2.72

6.93

2.4

3.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

488

1.86

6.90

1.7

2.5

0.30

0.87

g/l

1.64

435

(3024928) Oxygen saturation in Venous blood

417

1.93

6.87

3.0

2.9

57.86

63.22

1.45

407

(3009508) Creatinine [Moles/volume] in Urine

699

5844

1.29

6.80

3.1

3.6

8.02

8.22

mmol/l

0.49

616

5095

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

557

1.80

6.77

3.4

3.5

24.55

24.77

mmol/l

0.45

520

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.41

6.70

1.0

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

212

2.29

6.65

1.1

1.2

—

29.29

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

187

2.38

6.64

1.4

3.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

568

1.78

6.64

2.1

2.3

272.71

348.01

ug/l

0.22

532

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

104

607

1.75

6.58

2.1

2.5

182.15

177.53

0.20

583

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

526

1.80

6.54

1.3

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.83

6.53

1.2

1.1

98.32

98.26

0.00

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

468

1.85

6.52

1.8

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1964

18830

1.50

6.48

5.7

5.1

2.86

2.82

mmol/l

1.53

1886

17972

(3025159) Blasts/Leukocytes in Blood

227

1602

1.47

6.47

4.5

5.0

0.04

0.33

0.72

365

(3012501) Base excess in Blood by calculation

329

2.01

6.40

3.6

3.7

2.33

2.23

mmol/l

0.10

209

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

142

2.56

6.37

1.6

1.2

3.03

5.84

umol/l

5.85

127

(3014765) Yersinia sp identified in Stool by Organism specific culture

553

1.77

6.36

1.3

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

400

1.91

6.35

3.0

3.7

0.34

0.35

iu/ml

0.13

207

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

554

1.77

6.33

1.3

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

144

926

1.59

6.31

2.5

1.9

—

(3020891) Body temperature

114

691

1.69

6.31

4.8

4.5

36.89

36.94

°c

0.51

114

686

(3027945) Reticulocytes/Erythrocytes in Blood

229

1628

1.46

6.28

2.6

2.9

1.63

1.77

2.00

205

1481

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2113

20676

2.39

6.28

29.4

20.2

90.79

90.47

2.92

2107

20536

(3021901) Oxygen saturation in Capillary blood

311

2.02

6.26

3.3

2.7

92.35

90.43

2.33

303

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

186

2.34

6.26

1.1

1.3

0.14

0.56

u/ml

1.95

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2113

20680

2.37

6.21

30.0

20.7

41.21

41.53

0.44

2106

20534

(3026361) Erythrocytes [#/volume] in Blood

2113

20680

2.37

6.21

29.4

20.3

4.57

e12/l

0.00

2094

20344

(40767503) Oxygen content in Capillary blood by calculation

319

2.00

6.20

3.5

2.4

17.86

16.85

1.71

313

(3048929) Epstein Barr virus Ab [Presence] in Serum

135

859

1.61

6.19

1.3

—

(3011412) CD3 cells [#/volume] in Blood

181

2.35

6.17

1.6

2.4

1472.12

1333.29

e6/l

0.44

161

(3000060) B lymphocytes [#/volume] in Blood

3.53

6.16

1.5

1.9

0.27

0.17

e9/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

559

1.75

6.14

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1949

18686

1.47

6.12

5.1

4.6

4.76

4.73

mmol/l

0.73

1878

17902

(3010813) Leukocytes [#/volume] in Blood

2113

20686

2.36

6.10

29.5

20.4

6.85

6.69

e9/l

2.58

2092

20339

(3000963) Hemoglobin [Mass/volume] in Blood

2113

20689

2.35

6.04

29.7

20.4

137.76

137.32

g/l

0.81

2105

20550

(3035941) MCH [Entitic mass]

2112

20677

2.31

6.01

29.3

20.2

30.34

30.23

2.52

2106

20538

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1943

18632

1.45

5.95

5.1

4.5

1.41

1.45

mmol/l

3.45

1867

17768

(3007461) Platelets [#/volume] in Blood

2111

20669

2.27

5.90

29.6

20.3

263.30

257.22

e9/l

4.45

2096

20372

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

121

760

1.63

5.86

2.3

2.2

—

(4024509) Urine culture

114

706

1.65

5.84

1.9

1.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

3.80

5.81

1.2

1.1

0.02

0.11

u/ml

0.66

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

137

2.51

5.79

1.4

2.6

180.77

226.87

e6/l

1.20

119

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

356

1.91

5.77

1.3

1.2

3.39

4.35

u/ml

0.37

150

(3002179) Metamyelocytes/Leukocytes in Blood

220

1579

1.44

5.74

4.2

4.5

0.34

0.67

1.93

436

(3023520) Reticulocytes [#/volume] in Blood

174

1193

1.50

5.74

2.7

3.0

67.36

72.05

e9/l

1.23

125

863

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

102

619

1.68

5.65

2.0

2.1

3.42

4.08

iu/l

0.44

274

(3017181) Myelocytes/Leukocytes in Blood

228

1653

1.42

5.63

4.4

4.7

0.63

0.93

1.41

467

(3020779) Urea [Moles/volume] in Serum or Plasma

204

1449

1.45

5.63

6.5

8.5

6.74

8.40

mmol/l

4.46

199

1403

(3040151) Glucose [Moles/volume] in Capillary blood

164

2.34

5.59

3.5

5.4

9.17

7.16

mmol/l

0.29

140

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

353

1.90

5.58

1.7

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

135

2.47

5.46

1.4

2.5

494.00

583.63

e6/l

0.42

112

(3052851) Hemolysis interference index of Serum or Plasma

451

1.78

5.44

2.5

3.1

1.59

2.19

index

0.64

252

(3006184) Hemoglobin [Mass/volume] in Capillary blood

385

1.85

5.44

2.7

2.2

133.29

133.03

g/l

0.03

305

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

241

1776

1.40

5.43

6.9

5.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

626

5286

1.26

5.38

2.2

2.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

491

1.74

5.35

1.8

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

240

2.07

5.32

1.4

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

189

1339

1.45

5.30

2.5

2.3

5503.47

6365.09

u/l

0.11

518

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

346

1.88

5.26

1.0

1.1

131.32

116.60

3.10

322

(3021440) Promyelocytes/Leukocytes in Blood

218

1588

1.41

5.25

4.4

4.8

0.00

0.12

7.79

402

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

509

1.72

5.24

1.5

1.4

0.26

0.42

nmol/l

2.58

413

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

376

1.83

5.21

1.7

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

220

1608

1.41

5.20

2.3

2.4

0.22

g/l

0.02

208

1512

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

551

1.68

5.11

2.2

1.8

—

(3039000) Anion gap in Blood by calculation

309

1.90

5.00

6.9

10.3

10.83

11.58

mmol/l

1.14

280

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.98

4.99

1.1

1.5

67.31

91.00

nmol/24h

0.89

(3018572) Chloride [Moles/volume] in Blood

310

1.90

4.95

6.9

10.3

105.17

105.46

mmol/l

0.17

281

(44790049) Parainfluenza type 3 nucleic acid detection

254

1.99

4.95

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

254

1.99

4.95

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

254

1.99

4.95

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

254

1.99

4.95

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.23

4.89

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

112

2.52

4.88

1.4

2.0

1.33

1.90

u/field

0.36

(1616796) Gas panel - Central venous blood

365

1.81

4.77

4.2

3.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.59

4.76

1.1

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

258

1.96

4.75

1.6

1.3

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

102

2.57

4.72

1.5

1.4

—

80.00

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

133

2.35

4.67

1.7

2.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.86

4.66

1.2

1.1

84.50

95.14

—

(40768443) Skin Pathology biopsy report

113

740

1.56

4.65

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

110

716

1.57

4.65

1.5

1.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.51

4.61

1.1

1.0

6.22

6.82

mg/g

0.18

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

607

1.61

4.59

2.3

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

422

1.73

4.58

1.6

3.7

28.88

43.52

mg/l

0.93

356

(4195642) Thrombophilia screening test

341

1.81

4.56

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

423

1.73

4.55

1.6

3.7

38.12

56.75

mg/l

0.63

356

(3019225) pH of Specimen

201

1483

1.39

4.52

4.0

3.9

7.34

7.35

0.18

146

1089

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

271

1.90

4.47

1.1

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

100

2.52

4.38

1.0

1.1

100.40

93.51

0.57

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

600

1.59

4.34

1.3

1.1

2.97

4.10

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.35

4.32

1.1

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.02

4.31

7.3

4.8

39.67

44.00

umol/l

0.25

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.27

4.29

1.7

1.6

0.87

0.89

mg/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

6.27

4.29

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

594

1.59

4.28

2.0

2.38

1.93

ug/l

0.18

534

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

313

1.81

4.21

1.2

—

33.33

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

229

1750

1.35

4.14

3.5

4.7

220.43

244.24

u/l

1.48

220

1673

(3030313) Adrenal Ab [Titer] in Serum

5.26

4.14

1.1

1.0

—

(44813793) Dust mix specific IgE antibody measurement

155

2.15

4.06

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

214

1625

1.35

4.04

3.3

2.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

137

2.21

3.96

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

269

1.84

3.92

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

323

1.75

3.82

1.1

3.88

2.58

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

190

1432

1.36

3.78

3.3

4.5

8.76

23.82

ug/l

0.99

146

1132

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

196

1.96

3.68

1.9

2.1

19.66

20.06

nmol/l

0.10

188

(3047007) Chlamydophila sp Ab [Presence] in Serum

350

1.71

3.66

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

390

1.66

3.61

1.6

—

(3042517) Benzodiazepines panel - Urine

4.02

3.59

1.7

2.2

—

(3033099) Centromere Ab [Titer] in Serum

3.73

3.59

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

407

1.64

3.56

1.8

—

(40761536) Microorganisms panel - Urine sediment

201

1548

1.33

3.48

4.6

3.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1834

17679

1.26

3.43

4.3

3.9

1.37

1.30

mmol/l

3.57

1759

16758

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

357

1.67

3.43

1.8

3.3

7.36

8.06

pmol/l

0.27

357

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

374

1.65

3.38

1.7

3.6

2.15

2.04

ratio

0.04

208

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

293

1.72

3.28

1.7

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

155

1161

1.36

3.24

3.2

3.9

78.44

80.42

ng/l

0.10

141

1045

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1736

16661

1.22

3.23

24.2

16.5

333.34

333.24

g/l

0.18

1730

16567

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.51

3.21

1.3

1.2

77.17

98.34

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

612

1.49

3.21

1.2

1.1

—

(44806071) Cardiolipin IgM antibody measurement

3.81

3.18

1.1

—

(4268621) Lupus anticoagulant assay

259

1.75

3.15

2.4

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

105

2.20

3.09

1.3

1.5

126.96

140.04

nmol/l

0.56

105

(3002079) Sodium [Moles/time] in 24 hour Urine

2.27

3.03

1.3

1.4

140.29

171.96

mmol/24h

0.84

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

425

1.57

3.03

1.1

16.51

15.68

au/ml

0.04

124

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

606

1.47

2.97

1.0

1.1

2.63

4.86

eliau/ml

0.65

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.64

2.96

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.64

2.96

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.64

2.96

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.64

2.96

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

348

2929

1.22

2.93

1.8

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.70

2.89

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.72

2.88

3.5

2.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

471

1.52

2.88

2.1

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

5.40

2.87

1.0

1.2

6.29

10.15

u/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.26

2.87

1.1

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

497

1.51

2.83

1.3

272.88

245.20

u/ml

0.18

314

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

280

2312

1.24

2.83

2.4

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

369

1.59

2.82

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

532

4678

1.18

2.80

4.8

4.5

1.77

1.95

ug/l

0.61

485

4297

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.65

2.79

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

131

2.00

2.75

1.1

1.3

4.38

6.26

u/l

2.13

111

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

225

1.75

2.75

1.9

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

365

1.58

2.71

5.0

3.4

33.13

36.23

umol/l

0.41

345

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.25

2.70

2.1

2.5

0.40

1.02

ug/l

2.77

(3038026) Centromere Ab [Units/volume] in Serum

139

1.95

2.70

1.4

1.2

—

68.02

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

428

3705

1.19

2.69

4.1

3.7

21.02

21.18

0.07

178

1495

(21494755) Public health laboratory ask at order entry panel

222

2703

0.80

2.54

1.3

—

(3051651) Icteric interference index of Serum or Plasma

101

2.09

2.53

2.2

3.4

0.57

0.84

index

1.13

101

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.24

2.51

1.2

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

431

1.50

2.46

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.82

2.46

1.0

0.03

0.19

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

188

1.77

2.45

3.7

2.7

—

(3012516) Albumin [Mass/volume] in Urine

565

5042

1.16

2.45

3.3

3.6

44.22

48.37

mg/l

0.16

353

3294

(3003181) Sodium [Moles/volume] in Urine

272

1.63

2.44

1.5

1.3

62.53

64.51

mmol/l

0.11

232

(3045424) Erythrocytes [Presence] in Urine

118

893

1.34

2.38

2.1

2.2

0.08

0.81

estimate

0.44

316

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.65

2.36

1.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

214

1.69

2.33

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

621

1.40

2.32

1.1

2.38

2.53

u/ml

0.04

311

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

233

1930

1.23

2.31

2.2

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

487

1.45

2.31

3.1

2.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

463

1.46

2.29

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

148

1.83

2.29

2.5

3.1

22.24

14.07

index

1.05

101

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.90

2.25

1.0

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

570

5120

1.15

2.24

3.9

4.3

7.74

8.47

mg/mmol

0.14

347

3291

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

164

1.78

2.23

1.2

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

225

1.66

2.21

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

114

1.94

2.20

2.6

3.2

818.05

712.38

u/ml

0.09

114

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

165

1.77

2.19

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.25

2.17

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

519

1.42

2.17

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

614

1.38

2.13

1.3

—

(3017704) Immunofixation for Urine

2.21

2.11

1.1

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

423

1.46

2.08

1.3

1.4

28.91

23.12

u/l

0.65

356

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.08

2.07

1.6

1.4

10.29

13.66

u/l

1.54

(3044242) Glucose [Moles/volume] in Arterial blood

2.03

2.06

1.4

2.6

6.63

7.98

mmol/l

1.66

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

350

1.50

2.05

1.2

1.1

2917.55

1572.85

iu/ml

0.16

(3034426) Prothrombin time (PT)

2.18

2.04

1.5

1.2

27.13

28.46

0.63

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.08

2.01

1.1

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

111

1.90

2.01

1.0

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

232

1.61

1.99

1.7

—

(3037756) Immunofixation for Serum or Plasma

273

1.55

1.95

1.4

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.55

1.94

1.0

1.3

—

(3023419) Bacteria identified in Sputum by Culture

226

1.60

1.94

2.2

2.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

180

1.68

1.92

1.1

1.0

0.23

3.34

u/ml

0.97

(3003740) Influenza virus B Ag [Presence] in Specimen

517

1.39

1.88

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.09

1.86

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.40

1.85

1.5

3.2

10.76

10.54

kpa

0.09

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.40

1.85

1.5

3.2

4.85

4.91

kpa

0.08

(3035715) Granulocytes [#/volume] in Blood

351

1.46

1.84

2.9

3.7

3.90

4.02

e9/l

0.20

351

(3025468) Yersinia sp identified in Specimen by Organism specific culture

206

1.61

1.83

1.3

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

363

3201

1.16

1.83

1.6

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

303

1.50

1.80

1.6

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.05

1.80

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.05

1.80

1.1

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.80

1.6

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.80

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.80

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.80

1.6

1.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.76

1.79

1.1

1.4

—

(4015189) Microbial culture of sputum

2.76

1.79

1.5

3.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

429

1.41

1.78

6.5

6.7

2130.00

316.20

iu/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

177

1.65

1.76

1.3

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

145

1180

1.25

1.74

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

1.74

1.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

357

1.44

1.70

1.0

1.1

1.64

2.29

eliau/ml

0.68

177

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.01

1.69

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

141

1.71

1.68

3.1

3.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

204

1.58

1.65

1.2

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

318

1.46

1.65

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.98

1.64

1.5

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.98

1.64

1.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

213

1.56

1.62

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

311

1.46

1.62

1.9

1.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.58

1.61

2.2

1.9

34.40

38.29

umol/l

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

472

1.37

1.61

1.4

—

19.13

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

206

1.56

1.60

1.3

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.70

1.58

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

569

1.33

1.58

1.1

5.70

5.46

u/ml

0.05

305

(3008401) Mugwort IgE Ab [Units/volume] in Serum

543

1.34

1.57

1.1

0.44

1.07

u/ml

1.24

222

(3008295) Osmolality of Serum or Plasma

215

1.54

1.57

1.5

284.88

281.84

mosm/kgh2o

0.35

166

(3005988) Vibrio sp identified in Specimen by Organism specific culture

207

1.55

1.57

1.3

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

527

1.34

1.55

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

228

1965

1.18

1.55

1.6

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

281

1.47

1.55

3.3

3.9

410.08

1132.96

u/ml

0.36

264

(3010726) Horse dander IgE Ab [Units/volume] in Serum

536

1.34

1.55

1.1

0.56

1.73

u/ml

3.40

257

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

200

1.56

1.54

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

332

1.42

1.52

1.7

1.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

250

1.49

1.50

2.9

3.8

0.91

1.51

0.53

235

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.07

1.49

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.07

1.49

5.8

4.5

—

(3020650) Glucose [Presence] in Urine

1.95

1.48

1.8

1.7

0.00

0.04

estimate

0.49

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.44

1.48

1.1

1.0

57.18

7.48

u/ml

—

(4034850) Laboratory test

558

1.32

1.47

11.0

8.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

211

1.52

1.46

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

386

1.38

1.46

2.2

5.42

5.11

umol/l

0.09

286

(3002256) Pathology report gross observation

271

2383

1.16

1.44

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

447

1.35

1.44

1.1

3.10

4.53

u/ml

0.63

192

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.13

1.44

1.0

—

(3035933) Granulocytes/Leukocytes in Blood

440

1.35

1.41

2.8

3.5

54.88

57.49

0.88

440

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

228

1983

1.17

1.40

4.9

4.3

30.93

31.19

0.14

177

1440

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

1.40

1.0

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.78

1.39

1.5

1.7

29.12

28.24

umol/l

0.16

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.08

1.38

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

174

1.56

1.37

1.0

0.09

2.44

u/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

174

1.56

1.37

1.7

2.1

31.37

23.43

mg/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

124

0.40

1.36

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

548

1.31

1.36

2.9

3.9

97.07

2743.62

u/ml

0.84

473

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.95

1.36

1.4

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

699

1.27

1.35

1.6

366.67

0.24

iu/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

128

1.65

1.33

2.0

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

152

1.59

1.32

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

152

1.59

1.32

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

152

1.59

1.32

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.01

1.27

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.05

1.26

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

138

1.60

1.26

2.0

1.4

70.14

73.70

umol/l

0.50

138

(3035320) C reactive protein [Mass/volume] in Body fluid

154

1.56

1.26

3.2

2.3

27.07

32.80

mg/l

0.24

106

(3018001) Oat IgE Ab [Units/volume] in Serum

2.40

1.24

1.0

0.03

0.25

u/ml

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

619

1.27

1.23

1.5

2.0

1.44

1.47

g/l

0.12

544

(3028433) Virus identified in Specimen by Culture

1.91

1.22

1.2

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

172

1.52

1.20

1.3

1.6

42.31

55.16

0.72

111

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

137

1611

0.84

1.19

1.5

1.6

1072.01

1007.38

mu/l

0.28

117

1345

(3052592) Norovirus Ag [Presence] in Stool

2.31

1.18

1.3

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

439

1.31

1.14

1.5

1.4

131.33

153.27

au/ml

0.64

123

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

183

1.48

1.13

1.7

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

233

1.42

1.13

1.7

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

106

882

1.21

1.12

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

201

1.45

1.10

1.7

1.8

—

(3000330) Specific gravity of Urine by Test strip

757

1.22

1.09

3.5

2.7

1.02

ratio

0.18

688

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

177

1.47

1.08

1.2

1.1

—

1.53

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

426

1.30

1.07

1.1

0.87

0.22

u/ml

0.41

130

(3028679) Herpes simplex virus Ab [Presence] in Serum

153

1.51

1.06

1.3

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.93

1.06

1.5

—

0.82

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.93

1.06

1.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.12

1.05

1.0

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.12

1.05

1.6

1.2

1.18

mmol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

599

1.24

1.03

2.6

3.4

1.24

1.37

mg/l

0.81

559

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

438

1.29

1.03

1.3

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.84

1.02

1.3

1.4

17.74

17.33

umol/l

0.10

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

315

2867

1.12

1.02

2.8

0.69

ug/l

0.04

183

1605

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.69

1.01

1.0

1.1

—

7.93

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1058

0.82

1.01

1.1

0.58

0.65

ratio

—

103

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.00

1.00

1.7

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

684

0.78

0.99

1.9

1.8

—

(3002619) Bacteria identified in Specimen by Culture

1.84

0.98

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1109

0.83

0.98

1.1

1.53

1.52

g/l

0.14

1109

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.95

0.97

3.0

1.7

4.44

950007.23

nmol/l

—

(44806420) Estimation of glomerular filtration rate

258

1.36

0.97

2.4

2.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.77

0.94

1.9

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

115

983

1.18

0.94

1.5

1.3

229.49

219.00

miu/ml

0.12

492

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

111

948

1.18

0.92

1.8

2.96

4.59

mg/l

1.04

682

(3014271) Vancomycin [Susceptibility]

1.73

0.92

3.4

2.4

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.15

0.91

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

193

1.40

0.90

1.1

17.88

16.16

u/ml

0.07

(3001556) Androgen free Index in Serum or Plasma

2.07

0.89

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

154

0.58

0.88

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.61

0.87

1.1

1.3

—

72.22

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

169

1.42

0.87

1.5

1.7

—

(40768441) Liver Pathology biopsy report

144

1.46

0.87

1.9

1.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.72

0.86

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

179

1.40

0.84

1.0

0.30

0.81

u/ml

—

(3044927) Protein electrophoresis panel - Urine

137

1.46

0.84

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

178

0.62

0.83

1.2

1.9

—

843.49

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

381

1.27

0.82

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.88

0.81

1.0

2.3

—

9070.00

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.58

0.81

1.1

1.3

—

1104.29

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.79

0.0

3.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

606

0.80

0.78

1.4

1.5

56.98

59.86

ug/l

0.22

606

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.77

0.0

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

359

1.26

0.76

2.0

1.5

322.27

347.60

mu/l

0.38

293

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

132

1.44

0.76

2.2

2.6

48.91

43.80

0.48

(3051387) C reactive protein [Mass/volume] in Capillary blood

342

1.26

0.74

4.5

3.1

23.80

24.70

mg/l

0.06

235

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

141

1.42

0.74

1.4

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.84

0.73

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.00

0.72

1.8

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.80

0.72

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

841

1.16

0.71

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

168

1.37

0.71

1.0

1.1

109.74

111.96

pmol/l

0.08

168

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.93

0.70

1.2

1.0

—

(4146454) Self-monitoring of blood glucose

160

1.38

0.70

2.3

2.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.71

0.70

1.7

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.71

0.70

1.7

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.71

0.70

1.7

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.53

0.69

1.2

1.1

51.72

56.50

u/ml

0.07

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.85

0.68

1.0

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.85

0.68

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.85

0.68

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

409

3850

1.08

0.68

1.6

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

302

1.26

0.68

4.6

3.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

180

0.66

0.67

11.5

16.6

763.00

7940.78

nmol/l

0.50

175

(3005532) Lymphocytes/Leukocytes in Pleural fluid

1.59

0.65

1.6

1.4

57.43

54.38

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.62

0.65

1.6

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

1.43

0.63

2.1

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

858

0.86

0.63

1.6

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.67

0.61

5.4

8.5

12.04

10.84

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.1

—

44.40

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

2.4

—

1.06

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

139

1.37

0.60

2.7

2.6

—

(4211845) Urine protein measurement

1.50

0.59

2.3

2.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

482

1.19

0.59

1.1

5.45

3.51

u/ml

0.30

232

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.53

0.59

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

196

0.71

0.57

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.48

0.57

1.0

1.7

43.89

42.22

g/l

—

(3003694) ABO and Rh group [Type] in Blood

630

6058

1.06

0.55

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.54

0.55

1.5

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

194

0.72

0.54

1.9

2.6

4.81

1.56

g/24h

—

123

(3036670) Protein [Mass/volume] in Synovial fluid

1.58

0.54

1.2

—

38.84

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.54

0.53

1.0

1.7

—

(3000012) Reticulocyte production index

178

1.30

0.53

1.3

2.4

0.78

0.92

0.57

114

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.52

0.52

4.0

2.0

10.54

16.53

umol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

415

1.18

0.52

3.0

2.7

1.12

0.91

nmol/l

0.76

358

(3037121) Protein [Mass/volume] in Urine

592

1.15

0.52

3.0

3.9

4762.97

385.05

mg/l

0.49

276

(3017569) Oxygen content in Arterial blood

1.45

0.51

1.3

2.8

15.98

16.78

0.29

(40768795) Lymph node Pathology biopsy report

180

0.72

0.51

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

225

0.75

0.51

1.3

1.6

8.12

7.69

mmol/l

0.34

217

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

398

1.18

0.50

1.6

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.39

0.50

1.8

2.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

1.36

0.50

1.5

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

418

1.18

0.49

1.4

1.6

10309.08

12695.94

e6/l

0.22

288

(3016650) Hepatitis A virus Ab [Presence] in Serum

400

1.18

0.48

1.2

1.1

—

(21494434) Karyotype in Bone marrow

128

1.33

0.47

1.1

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

452

4330

1.06

0.46

1.8

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

173

1.27

0.46

1.5

1.4

160.58

220.95

pmol/l

0.51

173

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.39

0.46

1.5

1.1

6.62

17.17

u/l

5.33

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

103

1.36

0.45

2.3

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

915

0.89

0.44

1.5

56.81

59.15

ug/l

0.22

763

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.45

0.44

2.1

1.9

—

(3006462) Nitrate [Presence] in Urine

1.45

0.44

2.6

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.64

0.42

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.43

0.41

2.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.43

0.41

2.1

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

763

0.89

0.41

1.7

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.36

0.41

1.5

1.1

69.46

85.68

u/l

0.57

(3005011) Chlamydia sp Ab [Titer] in Serum

1.52

0.41

1.2

1.4

—

(40762814) Titanium [Mass/volume] in Blood

0.00

0.41

0.0

2.3

—

3.53

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

846

0.89

0.41

1.5

1.11

1.12

ratio

0.03

514

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

186

1.24

0.40

1.4

2.4

32.39

32.51

0.06

186

(3000093) Morphology [Interpretation] in Blood Narrative

141

1.28

0.40

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

106

1.32

0.39

2.3

1.5

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.29

0.36

2.4

1.9

25.33

30.27

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

848

0.90

0.35

1.5

1.17

1.18

ratio

0.03

518

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

848

0.90

0.35

1.5

0.97

0.95

ratio

0.22

516

(4035726) Immunohistochemistry procedure

136

1457

0.93

0.34

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

191

1.21

0.33

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.31

0.33

4.7

7.2

5.60

5.95

kpa

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.35

0.32

3.0

3.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.33

0.32

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

110

1.27

0.31

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.30

0.30

1.0

19.64

40.56

iu/ml

—

(3012441) Differential panel - Pleural fluid

111

1.26

0.30

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

837

0.92

0.29

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.30

0.28

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

121

0.74

0.27

1.1

1.2

—

(3024932) HLA-DR beta [Type]

1.21

0.26

1.0

1.1

—

(3024471) HLA-A [Type]

1.21

0.26

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

132

1.21

0.25

1.3

1.4

17.50

34.61

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

320

1.13

0.25

1.5

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

160

1.19

0.25

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.22

0.25

1.6

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

288

2981

0.96

0.24

2.1

1.9

3.58

3.54

ratio

0.23

211

2244

(3042733) HLA Ab [Presence] in Serum

1.17

0.24

5.2

4.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

380

0.89

0.23

1.5

1.6

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

134

1.20

0.23

1.1

1.2

7.19

8.22

mm/h

0.24

134

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.22

0.22

5.4

7.4

5.76

5.20

kpa

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

1.22

0.22

1.8

1.4

1.20

3.03

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

163

1.17

0.21

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

4.5

—

103.60

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

0.20

—

(3014891) Appearance of Pleural fluid

0.00

0.21

0.0

1.7

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

8.5

—

101.14

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

123

0.81

0.20

1.7

1.6

0.41

0.49

e9/l

—

123

(3050129) First trimester maternal screen panel - Serum or Plasma

100

1053

0.95

0.19

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.13

0.17

2.7

3.0

0.61

mmol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.16

0.16

2.4

3.6

1.56

1.22

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.14

0.16

1.8

1.4

10.25

8.20

ug/l

—

(3020491) Glucose [Moles/volume] in Blood

139

1.15

0.16

1.5

1.7

7.23

6.40

mmol/l

—

101

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.20

0.16

2.0

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

349

0.92

0.15

2.0

2.5

148.44

149.56

ug/min

0.00

220

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.78

0.15

1.2

1.8

96.35

101.90

ng/l

—

(3024263) Appearance of Synovial fluid

1.15

0.15

2.1

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.79

0.14

63.0

26.8

113.71

123.91

ug/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

139

0.86

0.14

1.1

1565.33

1509.14

miu/ml

0.07

139

(3043238) Trisomy 21 risk [Likelihood] in Fetus

726

0.95

0.14

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.17

0.13

1.0

1.1

81.68

195.48

iu/ml

2.67

(40768800) Prostate Pathology biopsy report

252

0.91

0.12

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

0.87

0.11

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

708

0.96

0.10

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

398

1.06

0.10

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

289

0.93

0.09

1.1

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

145

1.10

0.09

1.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.78

0.08

1.2

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.78

0.08

1.2

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.08

0.08

1.7

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.08

0.07

2.1

3.1

42.50

45.18

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.08

0.07

4.3

6.2

11.38

8.01

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.89

0.06

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

198

1.06

0.05

3.8

5.2

44.93

80.47

u/ml

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

224

2266

0.99

0.05

1.8

1.7

3.53

3.49

mmol/l

0.18

145

1543

(3001019) Free T4 and TSH panel - Serum or Plasma

143

1409

1.02

0.05

1.7

—

(3045142) Bone marrow Pathology biopsy report

179

1.06

0.05

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

179

1.06

0.05

1.2

1.1

—

(4281824) Cell count and differential, peritoneal fluid

179

1.06

0.05

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

436

1.03

0.05

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

316

3181

0.99

0.03

2.0

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

371

0.97

0.03

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

877

1.02

0.03

1.7

1.9

—

(3006270) Folate [Moles/volume] in Blood

128

0.94

0.02

1.0

1.1

496.17

393.69

nmol/l

0.83

120

(21494890) Protein electrophoresis panel - 24 hour Urine

138

0.94

0.02

1.6

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

152

1.05

0.02

1.2

1.3

6593.33

100840.21

e6/l

—

102

(40768793) Breast Pathology biopsy report

471

1.02

0.02

1.2

1.3

—

(3005033) Fetal Nuchal fold Thickness US

697

0.99

0.01

1.5

1.35

1.27

0.68

497

(1761868) Lipid panel - Serum or Plasma

883

8824

1.00

0.00

2.9

2.8

—

(3004451) EKG impression Narrative

1.05

0.00

1.6

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

115

0.96

0.00

5.7

7.5

6.70

155.99

ug/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

149

1.01

0.00

2.3

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

275

0.98

0.00

4.3

18.44

25.69

u/ml

0.84

270

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

385

0.99

0.00

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

106

1.04

0.00

1.5

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

196

1.02

0.00

1.1

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

266

1.02

0.00

2.7

3.2

20.31

65.40

u/ml

0.46

261

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

112

0.98

0.00

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

142

0.99

0.00

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

158

1.01

0.00

2.4

4.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

262

0.99

0.00

1.3

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

443

0.99

0.00

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.97

0.00

1.7

1.6

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

7.80

—

(4133840) Spirometry

0.93

-0.00

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

2.87

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.00

-0.00

1.1

1.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.99

-0.00

1.4

1.5

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

320.00

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.1

—

69.31

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.98

-0.00

1.4

1.5

—

(3022689) Creatine [Moles/volume] in Urine

0.93

-0.00

1.2

1.5

6.90

10.21

mmol/l

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.01

-0.00

1.0

1.1

—

5.20

—

(40768446) Kidney Pathology biopsy report

0.90

-0.00

1.4

1.6

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

26.50

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2800.00

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

254.67

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.88

-0.00

1.2

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.3

—

408.50

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

14.8

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

7.60

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

3.48

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

34.44

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.00

-0.00

1.1

1.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

36.41

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

0.47

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

-0.00

0.0

3.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

8861.20

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_CLUSTHEADACHE_STRICT_INCLAVO and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_CLUSTHEADACHE_STRICT_INCLAVO	0.92 [0.76, 1.12]	0.401
Birth year	0.992 [0.98, 1.0]	0.079

During the follow-up period (1.1.1998 — 31.12.2019), 184 out of 4534 females with G6_CLUSTHEADACHE_STRICT_INCLAVO died.

Males

Parameter	HR [95% CI]	p-value
G6_CLUSTHEADACHE_STRICT_INCLAVO	1.18 [1.02, 1.36]	0.022
Birth year	0.987 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 377 out of 5156 males with G6_CLUSTHEADACHE_STRICT_INCLAVO died.

Mortality risk

Mortality risk for people of age

years, who have G6_CLUSTHEADACHE_STRICT_INCLAVO.

N-year risk	Females	Males
1	0.061%	0.231%
5	0.422%	1.241%
10	1.148%	3.496%
15	2.343%	6.482%
20	4.264%	10.817%

Relationships between endpoints

↥

Index endpoint: G6_CLUSTHEADACHE_STRICT_INCLAVO – Cluster headache, strict, including avohilmo

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cluster headache, strict, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints